Introduction {#s1}
============

Atopic eczema is a very common inflammatory skin disorder [@pone.0039803-Gupta1]. Its prevalence appears to vary across the world as noted in key international epidemiological studies [@pone.0039803-Asher1]--[@pone.0039803-Warner1]. Such variation has been found in both children and adults and points to the likely importance of environmental risk factors. In addition, atopic eczema has been shown to cluster in families and there is growing evidence that it is an herald condition in many people who go on to develop allergic problems affecting other organ systems (e.g. food allergy) [@pone.0039803-Punekar1], [@pone.0039803-vandenOord1]. Genetics are important in the aetiology of atopic eczema: in particular, recent genetic epidemiological studies found a strong association between filaggrin gene defects (present in 1 in 10 Europeans and North Americans), and atopic eczema [@pone.0039803-vandenOord1]. Filaggrin plays a role in maintaining the epidermal skin barrier function, whereby it helps to retain moisture in the skin and limits penetration by allergens. These functions can be impaired in filaggrin loss-of-function mutations, this resulting in dry, scaly skin, which increases the risk of allergic sensitisation and disease [@pone.0039803-vandenOord1]--[@pone.0039803-Sandilands1].

Monitoring disease trends over time aids aetiological understanding and helps with the planning of health services nationally and internationally. Building on our previous work on asthma, we sought to describe international trends in the incidence and prevalence of atopic eczema [@pone.0039803-Anandan1]. We aimed to draw preferentially on high quality studies using appropriate study designs and, in particular, studies using validated instruments \[such as the International Study of Asthma and Allergies in Childhood (ISAAC) or the European Community Respiratory Health Survey (ECRHS)\] [@pone.0039803-ISAAC1], [@pone.0039803-The1].

Methods {#s2}
=======

This review is reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement as a guide (see [Appendix S1](#pone.0039803.s001){ref-type="supplementary-material"}) [@pone.0039803-Liberati1]. The methods for this review were specified in advance and documented in a study protocol.

Our full search strategy is given in [Appendix S2](#pone.0039803.s002){ref-type="supplementary-material"}. In short, we searched seven electronic databases, namely Medline, CINAHL, Embase, Global Health, Global Health Library, Google Scholar and Web of Knowledge, from 1 January 1990 to 19 May 2010 (date of last search). We used both Medical Subject Headings (MeSH) and free text terms of the following concepts: (atopic eczema OR atopic dermatitis) AND (cohort studies OR cross-sectional studies OR ISAAC OR ECRHS) AND (incidence OR prevalence OR trend). The searches were not limited by age, sex, ethnicity or language. Furthermore, bibliographies of key reports were scanned and a citation search was conducted for any additional papers of interest. We only included full-text reports of cohort studies, repeated cross-sectional surveys or analyses of routine healthcare datasets, as we considered these appropriate designs for the assessment of disease trends. Studies were required to present at least two estimates of atopic eczema incidence and/or prevalence within the period 1990 to 2010 and, at each assessment time point, they needed to use a similar approach and instrument (see [Table 1](#pone-0039803-t001){ref-type="table"}). The screening of titles and abstracts and the eligibility assessment of full-text reports was independently performed by two reviewers. Disagreements were resolved by discussion or by a third reviewer if agreement could not be reached. Similarly, to establish the methodological quality of each study, the internal and external validity was examined using the Critical Appraisal Skills Programme (CASP) tool [@pone.0039803-Public1] and scored as 'good', 'moderate' or 'poor'. This methodological assessment included for example an appraisal of whether validated instruments were used \[i.e. at least one of the ISAAC key questions (see [Table 2](#pone-0039803-t002){ref-type="table"})\]. Reviewers were not masked when assessing study quality. Incidence and/or prevalence data as well as study and participant characteristics were extracted onto a customised data extraction sheet by one reviewer and thoroughly checked by the second reviewer.

10.1371/journal.pone.0039803.t001

###### Inclusion criteria.

![](pone.0039803.t001){#pone-0039803-t001-1}

  -------------------------------------------------------------------------------------------------
  1\. Epidemiological design (e.g. cohort, repeated cross-sectional or routine health care)
  2\. Estimates of eczema incidence and or prevalence at least twice within the period 1990--2010
  3\. Use of a comparable approach and instrument to measure eczema at each time point.
  -------------------------------------------------------------------------------------------------

10.1371/journal.pone.0039803.t002

###### Key question for atopic eczema from the ISAAC questionnaire.

![](pone.0039803.t002){#pone-0039803-t002-2}

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Have you ***[ever]{.ul}*** had an itchy rash which was coming and going for at least six months?
  Have you had this itchy rash at any time ***[in the last 12 months?]{.ul}***
  Has this itchy rash ***[at any time]{.ul}*** affected any of the following places: the folds of the elbows, behind the knees, in front of the ankles, under the buttocks, or around the neck, ears or eyes?
  At what age did this itchy rash first occur; under 2 years, age 2-4 years or age 5 or more?
  Has this rash cleared completely at any time ***[during the last 12 months?]{.ul}***
  ***[In the last 12 months]{.ul}***, how often, on average, have you been kept awake at night by this itchy rash; never in the last 12 months, less than one night per week or one or more nights per week?
  Have you ***[ever]{.ul}*** had eczema?
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

To compare disease trends, our primary outcome measure was the lifetime prevalence of symptoms suggestive of atopic eczema or the incidence of atopic eczema (see [Table 3](#pone-0039803-t003){ref-type="table"}). We also collected data on the secondary outcomes, such as the lifetime prevalence of physician-diagnosed eczema or 12-month prevalence measures. There was too much heterogeneity of populations studied and methods employed to undertake meta-analysis.

10.1371/journal.pone.0039803.t003

###### Primary and secondary outcomes measures.
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  ------------------------ -------------------------------------------------------------
  **Primary outcomes**             Lifetime prevalence of atopic eczema symptoms
                                            Incidence of atopic eczema
  **Secondary outcomes**    Lifetime prevalence of physician diagnosis of atopic eczema
                                   12-month prevalence of atopic eczema symptoms
                            12-month prevalence of physician diagnosis of atopic eczema
  ------------------------ -------------------------------------------------------------

Results {#s3}
=======

Our searches retrieved 2,464 titles from which we identified 70 papers that satisfied our inclusion criteria (see [Figure 1](#pone-0039803-g001){ref-type="fig"}). We excluded one of these studies because the full-text paper was only available in Korean [@pone.0039803-Choi1] and we were unable to procure a translation; there were therefore 69 papers in our final dataset. Data from included studies judged to be of moderate or good quality are summarised in [Table 4](#pone-0039803-t004){ref-type="table"} and explored descriptively by region (see [Tables 5](#pone-0039803-t005){ref-type="table"}, [6](#pone-0039803-t006){ref-type="table"}, [7](#pone-0039803-t007){ref-type="table"}, [8](#pone-0039803-t008){ref-type="table"} and [9](#pone-0039803-t009){ref-type="table"}) [@pone.0039803-United1]. Data from the primary outcomes are additionally represented on a map (see [Figure 2](#pone-0039803-g002){ref-type="fig"}). Data from studies judged to be at greater risk of bias are available from the corresponding author [@pone.0039803-AlFrayh1]--[@pone.0039803-Saeki1]. Nearly all studies had prevalence data, while incidence data were only reported in three European studies [@pone.0039803-Olesen1]--[@pone.0039803-Simpson1]. Prevalence data are described using lifetime prevalence of atopic eczema symptoms.

![PRISMA flow diagram.](pone.0039803.g001){#pone-0039803-g001}

10.1371/journal.pone.0039803.t004

###### Summary of trends in different atopic eczema outcomes between 1990 and 2010 by region[\*](#nt101){ref-type="table-fn"}.
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  Region            Papers   Trends    Incidence   Lifetime prevalence   12-month prevalence                                               
  ---------------- -------- --------- ----------- --------------------- --------------------- --- --- --- ---- --- --- --- --- --- --- --- ---
  ***Africa***      **4**    **20**        0                0                     0            9   0   1   2    0   2   4   1   1   0   0   0
  ***Asia***        **20**   **61**                                                                                                        
  eastern             10       27          0                0                     0            7   2   0   7    1   1   7   1   0   0   0   1
  south-eastern       4        20          0                0                     0            2   4   0   1    3   0   4   6   0   0   0   0
  western             6        14          0                0                     0            1   0   3   0    3   2   0   2   2   0   0   1
  ***Americas***    **5**    **21**                                                                                                        
  North               0         0          0                0                     0            0   0   0   0    0   0   0   0   0   0   0   0
  Central             1         6          0                0                     0            0   0   2   2    0   0   0   0   2   0   0   0
  South               4        15          0                0                     0            0   5   0   0    1   3   0   5   1   0   0   0
  ***Europe***      **31**   **101**                                                                                                       
  western             10       42          1                1                     0            4   2   0   12   5   0   4   9   0   0   0   4
  southern            4        15          0                0                     0            1   1   0   4    1   0   5   1   0   2   0   0
  northern            15       41          1                1                     0            9   1   1   15   1   0   8   2   1   0   1   0
  eastern             2         3          0                0                     0            0   0   0   1    2   0   0   0   0   0   0   0
  ***Oceania***     **3**     **4**        0                0                     0            1   0   0   1    1   0   1   0   0   0   0   0

Based on UN classification [@pone.0039803-United1].

![World map of the incidence and lifetime prevalence of atopic eczema symptoms (1990--2010).\
Overview of absolute changes in the incidence of atopic eczema and lifetime prevalence of atopic eczema symptoms between 1990 and 2010.](pone.0039803.g002){#pone-0039803-g002}

Africa {#s3a}
------

As presented in [Table 4](#pone-0039803-t004){ref-type="table"}, we found four studies on atopic eczema trends for Africa [@pone.0039803-Bouayad1]--[@pone.0039803-Zar1]. Incidence was not measured in any of these studies. Prevalence was measured based on parental- or self-report as assessed by ISAAC-based questions (see [Table 5](#pone-0039803-t005){ref-type="table"}). Data were mainly from 13--14 year old children and in these children the general trend in Africa (Kenya, Morocco and South Africa) for the prevalence of atopic eczema was increasing [@pone.0039803-Simpson1], [@pone.0039803-Esamai1], [@pone.0039803-Falade1] [@pone.0039803-Bouayad1], [@pone.0039803-Esamai1], [@pone.0039803-Zar1]. In these children, an approximate doubling of the lifetime prevalence of atopic eczema symptoms was found for Morocco \[e.g. flexural rash in Marrakech, Morocco -- from 9.9% (1995) to 20.9% (2001--02)\] [@pone.0039803-Bouayad1], for South Africa \[e.g. flexural rash -- from 10.2% (1995) to 16.5% (2002)\] [@pone.0039803-Zar1] and for Kenya \[e.g. itchy recurrent rash in flexural areas -- from 11.4% (1995) to 19.8% (2001)\] [@pone.0039803-Esamai1]. In Nigeria in children of this age group, the lifetime prevalence of itchy rash decreased from a high baseline prevalence \[from 26.1% (1995) to 18.0% (2001--02)\] [@pone.0039803-Falade1]. Prevalence estimates in 2001--02 were, however, comparable for all countries. An approximate doubling was also seen in the lifetime prevalence of physician-diagnosed atopic eczema in 13--14 year olds in South Africa and Kenya [@pone.0039803-Esamai1], [@pone.0039803-Zar1]. In contrast, the prevalence of physician-diagnosed atopic eczema in Nigeria considerably decreased over a 5-year period from 1995 to 2001 in 6--7 year olds \[from 9.4% to 6.8%\] and in 13--14 year olds \[from 38.4% to 19.4%\] [@pone.0039803-Falade1]. The baseline estimate for 13--14 year olds was again extremely high. In other African countries, single estimates of atopic eczema prevalence may have been reported, but we were unable to locate any serial data on trends.

10.1371/journal.pone.0039803.t005

###### Good and moderate quality studies reporting the prevalence of parental- or self-report of atopic eczema between 1990 and 2010 in Africa.
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  Study                                                  Geographic area        Age range                              Outcome                               Time period    Baseline estimate   Final estimate   Summary measures      Conclusion                 Quality                       
  ------------------------------------------------- -------------------------- ----------- --------------------------------------------------------------- --------------- ------------------- ---------------- ------------------ ------------------- ----------------------------- ---------- ----------
  *Measures of symptoms of atopic eczema*                                                                                                                                                                                                                                                       
  Falade et al. (2009) [@pone.0039803-Falade1]           Nigeria (Ibadan)         6--7                     ISAAC-based parental-report of:                  1995/2001--02         1,696                               2,396                                  \% change (S.E.)                    Moderate
                                                                                                          lifetime prevalence of itchy rash                                                       7.7 (0.7)                            10.2 (0.6)          2.5 (0.9), P = 0.007       Increase  
                                                                                                          12-month prevalence of itchy rash                                                       4.5 (0.5)                             5.0 (0.5)          0.5 (0.7), P = 0.437        Stable   
  Falade et al. (2009) [@pone.0039803-Falade1]           Nigeria (Ibadan)        13--14                    ISAAC-based parental-report of:                  1995/2001--02         3,057                               3,142                                  \% change (S.E.)                    Moderate
                                                                                                          lifetime prevalence of itchy rash                                                       26.1 (0.8)                           18.0 (0.7)          −8.1 (1.0), P\<0.001       Decrease  
                                                                                                          12-month prevalence of itchy rash                                                       17.7 (0.7)                            7.7 (0.5)          −10.0 (0.8), P\<0.001      Decrease  
  Bouayad et al. (2006) [@pone.0039803-Bouayad1]       Morocco (Casablanca)      13--14                      ISAAC-based self-report of:                    1995/2001--02         3,178                               1,744                                 \% change per year                   Moderate
                                                                                                             lifetime prevalence of rash                                                             20.5                           34.2 (33.4--35.0)         2.28, P\<0.001          Increase  
                                                                                                        lifetime prevalence of flexural rash                                                         12.6                           23.9 (23.2--24.6)         1.88, P\<0.001          Increase  
                                                                                                             12-month prevalence of rash                                                             14.2                           26.1 (25.3--26.8)         1.98, P\<0.001          Increase  
  Bouayad et al. (2006) [@pone.0039803-Bouayad1]       Morocco (Marrakech)       13--14                      ISAAC-based self-report of:                    1995/2001--02         2,896                               1,677                                 \% change per year                   Moderate
                                                                                                             lifetime prevalence of rash                                                             20.4                           33.9 (33.1--34.7)         2.20, P\<0.001          Increase  
                                                                                                        lifetime prevalence of flexural rash                                                         9.9                            20.9 (20.2--21.7)         1.79, P\<0.001          Increase  
                                                                                                             12-month prevalence of rash                                                             13.1                           23.1 (22.3--23.8)         1.63, P\<0.001          Increase  
  Esamai et al. (2002) [@pone.0039803-Esamai1]         Kenya (Uasin Gishu)       13--14                      ISAAC-based self-report of:                      1995/2001           3,018                               3,258                                                                      Moderate
                                                                                                     lifetime prevalence of itchy recurrent rash                                                     23.8                                 28.5                   P = 0.001            Increase  
                                                                                            lifetime prevalence of itchy recurrent rash in flexural areas                                            11.4                                 19.8                   P = 0.001            Increase  
                                                                                                      12-month prevalence itchy recurrent rash                                                       14.4                                 21.3                   P = 0.001            Increase  
  Zar et al. (2007) [@pone.0039803-Zar1]             South Africa (Cape Town)    13--14                      ISAAC-based self-report of:                      1995/2002           5,161                               5,019                                     OR (95%CI)                       Moderate
                                                                                                          lifetime prevalence of itchy rash                                                          15.5                                 26.2          1.93 (1.75--2.14), P\<0.001   Increase  
                                                                                                        lifetime prevalence of flexural rash                                                         10.2                                 16.5          1.75 (1.56--1.97), P\<0.001   Increase  
                                                                                                           12-month prevalence itchy rash                                                            11.8                                 19.4          1.77 (1.56--1.97), P\<0.001   Increase  
  *Measures of physician-diagnosed atopic eczema*                                                                                                                                                                                                                                               
  Falade et al. (2009) [@pone.0039803-Falade1]           Nigeria (Ibadan)         6--7                     ISAAC-based parental-report of:                  1995/2001--02         1,696                               2,396                                  \% change (S.E.)                    Moderate
                                                                                              lifetime prevalence of physician-diagnosed atopic eczema                                            9.4 (0.7)                             6.8 (0.5)          −2.6 (0.9), P = 0.003      Decrease  
  Falade et al. (2009) [@pone.0039803-Falade1]           Nigeria (Ibadan)        13--14                      ISAAC-based self-report of:                    1995/2001--02         3,057                               3,142                                  \% change (S.E.)                    Moderate
                                                                                              lifetime prevalence of physician-diagnosed atopic eczema                                            38.4 (0.9)                           19.4 (0.7)          −19.0 (1.1), P\<0.001      Decrease  
  Esamai et al. (2002) [@pone.0039803-Esamai1]         Kenya (Uasin Gishu)       13--14                      ISAAC-based self-report of:                      1995/2001           3,018                               3,258                                                                      Moderate
                                                                                                        lifetime prevalence of atopic eczema                                                         13.9                                 28.5                   P = 0.001            Increase  
  Zar et al. (2007) [@pone.0039803-Zar1]             South Africa (Cape Town)    13--14                      ISAAC-based self-report of:                      1995/2002           5,161                               5,019                                     OR (95% CI)                      Moderate
                                                                                              lifetime prevalence of physician-diagnosed atopic eczema                                               9.6                                  16.7          1.88 (1.67--2.12), P\<0.001   Increase  

Abbreviations -- CI: confidence intervals, SE: standard error, OR: odds ratio.

Based on UN classification [@pone.0039803-United1].

95% CI and SE are only reported if included in original report.

Asia {#s3b}
----

For Asia, we summarised 20 papers representing 61 measures of trends in [Table 4](#pone-0039803-t004){ref-type="table"}. The majority of data came from eastern Asia [@pone.0039803-Kusunoki1]--[@pone.0039803-Yura1], whereas south-eastern Asia [@pone.0039803-Quah1]--[@pone.0039803-Wang2] and western Asia [@pone.0039803-Abramidze1]--[@pone.0039803-RomanoZelekha1] were represented to a lesser extent. For other regions in Asia, we found no relevant data. Here too no study assessed trends in incidence; rather, each study measured prevalence as based on parental- or self-report by questionnaires (see [Tables 6](#pone-0039803-t006){ref-type="table"}). Trends were found for different age groups in 12 different countries and showed no overall pattern.

10.1371/journal.pone.0039803.t006

###### Good and moderate quality studies reporting the prevalence of parental- or self-report of atopic eczema between 1990 and 2010 in Asia.
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  Study                                                                       Geographic area            Age range                                   Outcome                                      Time period      Baseline estimate    Final estimate     Summary measures      Conclusion                   Quality                         
  ------------------------------------------------------------------ ---------------------------------- ----------- ------------------------------------------------------------------------- ------------------- ------------------- ------------------- ------------------ ------------------- --------------------------------- ---------- ----------
  Eastern Asia[\*](#nt106){ref-type="table-fn"}                                                                                                                                                                                                                                                                                               
  *Measures of symptoms of atopic eczema*                                                                                                                                                                                                                                                                                                     
  Liao MF et al. (2009) [@pone.0039803-Liao1]                         Central Taiwan (Changhwa County)     6--8                          ISAAC-based parental-report of:                           2002/2007             7,040                                  4,622                                      POR (95% CI)                          Good
                                                                                                                                       lifetime prevalence of chronic rash                                                                    5.8                                    7.7            1.39 (1.20--1.61), P\<0.001     Increase  
                                                                                                                          lifetime prevalence of chronic rash with typical distribution                                                       5.9                                    8.9            1.56 (1.34--1.83), P\<0.001     Increase  
                                                                                                                                       12-month prevalence of chronic rash                                                                    7.0                                    9.7            1.45 (1.25--1.67), P\<0.001     Increase  
  Liao PF et al. (2009) [@pone.0039803-Liao2]                                      Taiwan                  6--15                         ISAAC-based parental-report of:                           1994/2002            75,960                                  11,580                                    No formal test                       Moderate
                                                                                                                              12-month prevalence of current atopic eczema symptoms                                                           1.5                                    2.8                        --                  Increase  
  Lee et al. (2007) [@pone.0039803-Lee2]                                           Taiwan                 12--15                         ISAAC-based parental-report of:                         1995--96/2001          42,919                                  10,215                                 Adjusted PR (95% CI)                      Good
                                                                                                                     Sex- and age-standardised lifetime prevalence of atopic eczema symptoms                                                  2.4                                    4.0            1.61 (1.42--1.81), P\<0.001     Increase  
  Yan et al. (2005) [@pone.0039803-Yan1]                                      Taiwan (Taipei)             13--14                           ISAAC-based self-report of:                         1994--95/2001--02        11,400                                  6,303                                                                          Moderate
                                                                                                                      12-month prevalence of recurrent itchy rash in a typical distribution                                             1.4 (1.1--1.6)                         4.1 (3.6--4.6)                P\<0.001               Increase  
  Lee et al. (2004) [@pone.0039803-Lee1]                                     China (Hong Kong)             6--7                          ISAAC-based parental-report of:                           1995/2001             3,618                                  4,448                                       OR (95% CI)                        Moderate
                                                                                                                                       lifetime prevalence of chronic rash                                                                    5.7                                    5.4            0.95 (0.79--1.15), P = 0.56      Stable   
                                                                                                                              lifetime prevalence of chronic rash at typical areas                                                            4.2                                    3.6            0.85 (0.68--1.07), P = 0.18      Stable   
                                                                                                                                       12-month prevalence of chronic rash                                                                    4.2                                    4.2            1.00 (0.80--1.25), P = 1.00      Stable   
  Wang et al. (2006) [@pone.0039803-Wang1]                                 China (Guangzhou city)         13--14                           ISAAC-based self-report of:                           1994--95/2001           3,855                                  3,516                                                                          Moderate
                                                                                                                             lifetime prevalence of flexural atopic eczema symptoms                                                     1.7 (1.3--2.1)                         3.0 (2.4--3.6)                 P\<0.05               Increase  
                                                                                                                             12-month prevalence of flexural atopic eczema symptoms                                                     1.3 (0.9--1.7)                         2.2 (1.7--2.7)                P = 0.002              Increase  
  Oh et al. (2004) [@pone.0039803-Oh1]                                             Korea                   6--12                         ISAAC-based parental-report of:                           1995/2000            25,361                                  27,425                                    No formal test                       Moderate
                                                                                                                               lifetime prevalence of itchy atopic eczema symptoms                                                     15.3 (14.9--15.8)                      17.0 (16.5--17.4)                                     Increase  
                                                                                                                          12-month prevalence of itchy flexural atopic eczema symptoms                                                  7.3 (7.0--7.6)                        10.7 (10.4--11.1)                                     Increase  
  Oh et al. (2004) [@pone.0039803-Oh1]                                             Korea                  12--15                         ISAAC-based parental-report of:                           1995/2000            15,068                                  14,777                                    No formal test                       Moderate
                                                                                                                               lifetime prevalence of itchy atopic eczema symptoms                                                      7.2 (6.8--7.7)                         9.3 (8.8--9.8)                                       Increase  
                                                                                                                          12-month prevalence of itchy flexural atopic eczema symptoms                                                  3.9 (3.6--4.3)                         6.1 (5.7--6.5)                                       Increase  
  Kusunoki et al. (2009) [@pone.0039803-Kusunoki1]                             Japan (Kyoto)               7--15                               Parental-report of:                                 1996/2006            16,176                                  13,215                                                                         Moderate
                                                                                                                              lifetime prevalence of symptoms of atopic dermatitis                                                           10.1                                   13.6                     P\<0.0001              Increase  
                                                                                                                              12-month prevalence of symptoms of atopic dermatitis                                                            4.2                                    5.6                     P\<0.0001              Increase  
  *Measures of physician-diagnosed atopic eczema*                                                                                                                                                                                                                                                                                             
  Liao MF et al. (2009) [@pone.0039803-Liao1]                             Taiwan (Changhwa County)         6--8                          ISAAC-based parental-report of:                           2002/2007             7,040                                  4,622                                      POR (95% CI)                          Good
                                                                                                                            lifetime prevalence of physician-diagnosed atopic eczema                                                         18.0                                   23.9            1.44 (1.31--1.57), P\<0.001     Increase  
  Liao PF et al. (2009) [@pone.0039803-Liao2]                                      Taiwan                  6--15                         ISAAC-based parental-report of:                           1994/2002            75,960                                  11,580                                    No formal test                       Moderate
                                                                                                                                      lifetime prevalence of atopic eczema                                                                    1.9                                    3.4                                            Increase  
  Lee et al. (2005) [@pone.0039803-Lee3]                                           Taiwan                 12--15                         ISAAC-based parental-report of:                         1995--96/2001          44,104                                  11,048                                    No formal test                       Moderate
                                                                                                                            lifetime prevalence of physician-diagnosed atopic eczema                                                          1.6                                    2.8                                            Increase  
  Yan et al. (2005) [@pone.0039803-Yan1]                                      Taiwan (Taipei)             13--14                           ISAAC-based self-report of:                         1994--95/2001--02        11,400                                  6,303                                                                          Moderate
                                                                                                                                      lifetime prevalence of atopic eczema                                                             11.8 (11.2--12.4)                      17.4 (16.4--18.3)              P\<0.001               Increase  
  Lee et al. (2004) [@pone.0039803-Lee1]                                     China (Hong Kong)             6--7                          ISAAC-based parental-report of:                           1995/2001             3,618                                  4,448                                       OR (95% CI)                        Moderate
                                                                                                                                      lifetime prevalence of atopic eczema                                                                   28.1                                   30.7            1.13 (1.03--1.25), P = 0.01     Increase  
  Wang et al. (2006) [@pone.0039803-Wang1]                                 China (Guangzhou city)         13--14                           ISAAC-based self-report of:                           1994--95/2001           3,855                                  3,516                                                                          Moderate
                                                                                                                            lifetime prevalence of physician-diagnosed atopic eczema                                                   18.3 (17.1--19.5)                      17.6 (16.3--18.9)              P = 0.462               Stable   
  Oh et al. (2004) [@pone.0039803-Oh1]                                             Korea                   6--12                         ISAAC-based parental-report of:                           1995/2000            25,361                                  27,425                                    No formal test                       Moderate
                                                                                                                            lifetime prevalence of physician-diagnosed atopic eczema                                                   16.6 (16.2--17.1)                      24.9 (24.4--25.4)                                     Increase  
  Oh et al. (2004) [@pone.0039803-Oh1]                                             Korea                  12--15                         ISAAC-based parental-report of:                           1995/2000            15,068                                  14,777                                    No formal test                       Moderate
                                                                                                                            lifetime prevalence of physician-diagnosed atopic eczema                                                    7.3 (6.9--7.7)                        12.8 (12.3--13.3)                                     Increase  
  Yura et al. (2001) [@pone.0039803-Yura1]                                Japan (Osake Prefecture)         7--12                               Parental-report of:                                 1993/1997            514,656                                458,284                                    No formal test                       Moderate
                                                                                                                          lifetime prevalence of physician-diagnosed atopic dermatitis                                                       24.1                                   22.9                                            Decrease  
                                                                                                                          12-month prevalence of physician-diagnosed atopic dermatitis                                                        6.8                                    5.7                                            Decrease  
  **South-eastern Asia** [\*](#nt106){ref-type="table-fn"}                                                                                                                                                                                                                                                                                    
  *Measures of symptoms of atopic eczema*                                                                                                                                                                                                                                                                                                     
  Wang et al. (2004) [@pone.0039803-Wang2]                                       Singapore                 6--7                          ISAAC-based parental-report of:                           1994/2001             2,030                                  5,305                                    \% Change (S.E.)                        Good
                                                                                                                                       lifetime prevalence of chronic rash                                                                10.5 (1.2)                             12.5 (0.5)            2.0 (1.3), P = 0.194          Stable   
                                                                                                                          lifetime prevalence of chronic rash with typical distribution                                                    6.1 (0.9)                              9.8 (0.4)            3.7 (1.0), P = 0.028         Increase  
                                                                                                                                       12-month prevalence of chronic rash                                                                 8.9 (1.1)                             11.0 (0.4)            2.1 (1.2), P = 0.155          Stable   
  Wang et al. (2004) [@pone.0039803-Wang2]                                       Singapore                12--15                         ISAAC-based parental-report of:                           1994/2001             4,208                                  4,058                                    \% Change (S.E.)                        Good
                                                                                                                                       lifetime prevalence of chronic rash                                                                12.3 (0.5)                             14.9 (0.6)            2.6 (0.8), P = 0.056          Stable   
                                                                                                                          lifetime prevalence of chronic rash with typical distribution                                                    7.0 (0.4)                             10.2 (0.5)             3.2 (0.6), P\<0.001         Increase  
                                                                                                                                       12-month prevalence of chronic rash                                                                 9.5 (0.5)                             11.6 (0.5)            2.1 (0.7), P = 0.034         Increase  
  Quah et al. (2005) [@pone.0039803-Quah1]                                 Malaysia (Kota Bharu)           6--7                          ISAAC-based parental-report of:                           1995/2001             3,939                                  3,157                                   \% Change (95% CI)                       Good
                                                                                                                                   12-month prevalence of flexural itchy rash                                                                14.0                                   17.6             3.6 (1.3--5.9), P = 0.004      Increase  
  Quah et al. (2005) [@pone.0039803-Quah1]                                 Malaysia (Kota Bharu)          13--14                         ISAAC-based parental-report of:                           1995/2001             3,116                                  3,004                                   \% Change (95% CI)                       Good
                                                                                                                                   12-month prevalence of flexural itchy rash                                                                12.1                                   13.4            1.3 (--4.6--7.1), P = 0.11       Stable   
  Trakultivakorn et al. (2007) [@pone.0039803-Trakultivakorn1]             Thailand (Chiang Mai)           6--7                          ISAAC-based parental-report of:                           1995/2001             3,828                                  3,106                                                                          Moderate
                                                                                                                                  12-month prevalence of atopic eczema symptoms                                                              11.4                                   16.3                      P\<0.01               Increase  
  Trakultivakorn et al. (2007) [@pone.0039803-Trakultivakorn1]               Thailand (Bangkok)            6--7                          ISAAC-based parental-report of:                           1995/2001             3,628                                  3,430                                                                          Moderate
                                                                                                                                  12-month prevalence of atopic eczema symptoms                                                              12.5                                   13.3                     P = 0.33                Stable   
  Teeratakulpisarn et al. (2004) [@pone.0039803-Teeratakulpisarn1]          Thailand (Northeast)           6--7                                parental-report of:                               1998--99/2003           2,658                                  2,119                                     No formal test                       Moderate
                                                                                                                                           lifetime prevalence of rash                                                                       18.0                                   17.2                                             Stable   
                                                                                                                                           12-month prevalence of rash                                                                       15.2                                   14.7                                             Stable   
  Trakultivakorn et al. (2007) [@pone.0039803-Teeratakulpisarn1]           Thailand (Chiang Mai)          13--14                         ISAAC-based parental-report of:                           1995/2001             3,927                                  3,538                                                                          Moderate
                                                                                                                                  12-month prevalence of atopic eczema symptoms                                                               9.6                                    8.6                     P = 0.63                Stable   
  Trakultivakorn et al. (2007) [@pone.0039803-Teeratakulpisarn1]             Thailand (Bangkok)           13--14                         ISAAC-based parental-report of:                           1995/2001             3,713                                  4,669                                                                          Moderate
                                                                                                                                  12-month prevalence of atopic eczema symptoms                                                               6.8                                   10.4                      P\<0.01               Increase  
  Teeratakulpisarn et al. (2004) [@pone.0039803-Teeratakulpisarn1]          Thailand (Northeast)          13--14                               parental-report of:                               1998--99/2003           3,410                                  2,956                                     No formal test                       Moderate
                                                                                                                                           lifetime prevalence of rash                                                                        9.9                                   10.9                                             Stable   
                                                                                                                                           12-month prevalence of rash                                                                        7.4                                    8.7                                             Stable   
  *Measures of physician-diagnosed atopic eczema*                                                                                                                                                                                                                                                                                             
  Wang et al. (2004) [@pone.0039803-Wang2]                                       Singapore                 6--7                          ISAAC-based parental-report of:                           1994/2001             2,030                                  5,305                                    \% Change (S.E.)                        Good
                                                                                                                            lifetime prevalence of physician-diagnosed atopic eczema                                                       3.0 (0.7)                              8.8 (0.4)             5.8 (0.8), P\<0.001         Increase  
  Wang et al. (2004) [@pone.0039803-Wang2]                                       Singapore                12--15                         ISAAC-based parental-report of:                           1994/2001             4,208                                  4,058                                    \% Change (S.E.)                        Good
                                                                                                                            lifetime prevalence of physician-diagnosed atopic eczema                                                       4.1 (0.3)                              5.8 (0.4)            1.7 (0.5), P = 0.810          Stable   
  Teeratakulpisarn et al. (2004) [@pone.0039803-Teeratakulpisarn1]          Thailand (Northeast)           6--7                                Parental-report of:                               1998--99/2003           2,658                                  2,119                                     No formal test                       Moderate
                                                                                                                                      lifetime prevalence of atopic eczema                                                                   30.5                                   29.2                                             Stable   
  Teeratakulpisarn et al. (2004) [@pone.0039803-Teeratakulpisarn1]          Thailand (Northeast)          13--14                                 Self-report of:                                 1998--99/2003           3,410                                  2,956                                     No formal test                       Moderate
                                                                                                                                      lifetime prevalence of atopic eczema                                                                   24.4                                   26.8                                             Stable   
  **Western Asia** [\*](#nt106){ref-type="table-fn"}                                                                                                                                                                                                                                                                                          
  *Measures of symptoms of atopic eczema*                                                                                                                                                                                                                                                                                                     
  Abramidze et al. (2006) [@pone.0039803-Abramidze1]                         Georgia (Tbilisi)             6--7                          ISAAC-based parental-report of:                           1996/2003             6,770                                  6,002                                        \% Change                         Moderate
                                                                                                                             lifetime prevalence of symptoms of flexural dermatitis                                                           4.5                                    3.4                   −1.1, P\<0.05            Decrease  
                                                                                                                                        current prevalence of itchy rash                                                                      5.3                                    5.8             0.5, P = not significant        Stable   
  Abramidze et al. (2006) [@pone.0039803-Abramidze1]                         Georgia (Kutaisi)             6--7                          ISAAC-based parental-report of:                           1996/2003                                                                                                 \% Change                         Moderate
                                                                                                                             lifetime prevalence of symptoms of flexural dermatitis                                                           5.2                                    2.4                   −2.8, P\<0.05            Decrease  
                                                                                                                                        current prevalence of itchy rash                                                                      6.1                                    3.4                   −2.7, P\<0.05            Decrease  
  Abramidze et al. (2007) [@pone.0039803-Abramidze2]                   Georgia (Tbilisi and Kutaisi)      13--14                           ISAAC-based self-report of:                             1996/2003             6,746                                  5,653                                        \% Change                         Moderate
                                                                                                                                        current prevalence of itchy rash                                                                      4.1                                    4.3             0.2, P = not significant        Stable   
  Owayed et al. (2008) [@pone.0039803-Owayed1]                                     Kuwait                 13--14                           ISAAC-based self-report of:                         1995--96/2001--02         3,110                                  2,822                                                                          Moderate
                                                                                                                                         lifetime prevalence itchy rash                                                                17.5 (16.2--18.8)                      10.6 (9.5--11.7)               P\<0.001               Decrease  
                                                                                                                                        12-month prevalence of itchy rash                                                              12.6 (11.4--13.8)                       8.3 (7.3--9.3)                P\<0.001               Decrease  
  Romano-Zelekha et al. (2007) [@pone.0039803-RomanoZelekha1]                      Israel                 13--14                           ISAAC-based self-report of:                             1997/2003            10,057                                  8,978                                                                          Moderate
                                                                                                                           lifetime prevalence of itchy rash in a typical distribution                                                        5.9                                    8.7                      P\<0.05               Increase  
  *Measures of physician-diagnosed atopic eczema*                                                                                                                                                                                                                                                                                             
  Abramidze et al. (2006) [@pone.0039803-Abramidze1]                         Georgia (Tbilisi)             6--7                          ISAAC-based parental-report of:                           1996/2003             6,770                                  6,002                                        \% Change                         Moderate
                                                                                                                            lifetime prevalence of physician-diagnosed atopic eczema                                                         11.6                                    3.6                    −8, P\<0.05             Decrease  
  Abramidze et al. (2006) [@pone.0039803-Abramidze1]                         Georgia (Kutaisi)             6--7                          ISAAC-based parental-report of:                           1996/2003                                                                                                 \% Change                         Moderate
                                                                                                                            lifetime prevalence of physician-diagnosed atopic eczema                                                          4.7                                    1.8                   −2.9, P\<0.05            Decrease  
  Abramidze et al. (2007) [@pone.0039803-Abramidze2]                   Georgia (Tbilisi and Kutaisi)      13--14                           ISAAC-based self-report of:                             1996/2003             6,746                                  5,653                                        \% Change                         Moderate
                                                                                                                            lifetime prevalence of physician-diagnosed atopic eczema                                                          3.0                                    2.6             −0.4, P = not significant       Stable   
  Owayed et al. (2008) [@pone.0039803-Owayed1]                                     Kuwait                 13--14                           ISAAC-based self-report of:                         1995--96/2001--02         3,110                                  2,822                                        P = 0.101                         Moderate
                                                                                                                            lifetime prevalence of physician-diagnosed atopic eczema                                                   11.3 (10.2--12.4)                       12.8 (11.6--14)                                       Stable   
  Kalyoncu et al. (1999) [@pone.0039803-Kalyoncu1]                            Turkey (Ankara)              6--13                           ISAAC-based self-report of:                             1992/1997             1,036                                   738                                    P = not significant                    Moderate
                                                                                                                          lifetime prevalence of physician-diagnosed atopic dermatitis                                                  6.1 (4.7--7.7)                         6.5 (4.8--8.5)                                        Stable   
  Demir et al. (2010) [@pone.0039803-Demir1]                                  Turkey (Ankara)              7--12                               Parental-report of:                                 1992/2007             1,036                                   442                                       Adjusted POR                        Moderate
                                                                                                                                       current prevalence of atopic eczema                                                              4.0 (2.8--5.2)                         1.2 (0.2--2.2)     0.4 (0.2--1.0), P trend = 0.004   Decrease  

Abbreviations -- CI: confidence intervals, SE: standard error, OR: odds ratio, POR: prevalence odds ratio, PR: prevalence ratio.

Based on UN classification [@pone.0039803-United1].

95% CI or SE are only reported if included in original report.

Point estimate extracted from graph or chart.

In eastern Asia, the general trend for atopic eczema prevalence was mainly increasing across different age groups. Lee et al. (2007) reported an increase in the sex- and age-standardised lifetime prevalence of ISAAC-based parental-report of atopic eczema symptoms in Taiwan among 12--15 year olds \[from 2.4% (1995--96) to 4.0% (2001)\] [@pone.0039803-Lee2]. The lifetime prevalence of atopic eczema symptoms also increased in Korea in the same age group \[from 7.2% (1995) to 9.3% (2000)\] [@pone.0039803-Oh1], in China (Guangzhou city) in a similar age group 13--14 \[from 1.7% (1994--95) to 3.0% (2001)\] [@pone.0039803-Wang1] and in Japan in a wider-ranged age group 7--15 \[from 10.1% (1996) to 13.6% (2006)\] [@pone.0039803-Yura1]. Moreover, baseline prevalences were low, but considerably higher in Korea and Japan, compared to Taiwan and China. In a slightly younger age group 6--12 in Korea, atopic eczema symptoms showed a modest increase from a substantially higher baseline prevalence \[from 15.3% (1995) to 17.0% (2000)\] [@pone.0039803-Oh1]. In the youngest children aged 6--7, the prevalence of atopic eczema symptoms was stable in Hong Kong \[e.g. chronic rash -- from 5.7% (1995) to 5.4% (2001)\] [@pone.0039803-Lee1], whilst a modest increase was seen in a later study in Taiwan in a similar age group 6--8 \[e.g. chronic rash - from 5.8% (2002) to 7.7% (2007)\] [@pone.0039803-Liao1]. Trends in the lifetime prevalence of physician-diagnosed atopic eczema followed nearly the same pattern as the lifetime prevalence of atopic eczema symptoms; trends were increasing in most countries among different age groups with only few exceptions.

In south-eastern Asia, the prevalence of different atopic eczema symptoms showed mixed trends. For chronic rash, the lifetime prevalence was stable in 6--7 year olds in Singapore \[10.5% (1994) and 12.5% (2001)\] [@pone.0039803-Trakultivakorn1] and in north-eastern Thailand \[18.0% (1998--99) and 17.2% (2003)\] [@pone.0039803-Teeratakulpisarn1]. Moreover, this prevalence also remained stable in older children (aged 12--15) in Singapore and, even though the baseline prevalence was appreciably lower, in 13--14 year olds in north-eastern Thailand. For chronic rash with a typical distribution, however, the lifetime prevalence was increasing in Singapore in children of both age groups \[e.g. in 6--7 year olds -- from 6.1% (1994) to 9.8% (2001)\] [@pone.0039803-Wang2]. In Malaysia and two specific geographical areas in Thailand (Chiang Mai and Bangkok) only data regarding the 12-month prevalence of atopic eczema symptoms were available [@pone.0039803-Quah1], [@pone.0039803-Teeratakulpisarn1]. In Malaysia and Chiang Mai, the 12-month prevalence of atopic eczema symptoms increased in 6--7 year olds, but was stable in 13--14 year olds, whereas the opposite was seen in Bangkok.

In western Asia, data were found for Georgia, Kuwait, Turkey and Israel [@pone.0039803-Abramidze1]--[@pone.0039803-RomanoZelekha1]. In Georgia, the lifetime prevalence of atopic eczema symptoms was found to be decreasing in two different geographical areas among 6--7 year olds: in Tbilisi \[from 4.5% (1996) to 3.4% (2003)\] and in Kutaisi \[from 5.2% (1996) to 2.4% (2003)\] [@pone.0039803-Abramidze1]. This trend was additionally apparent in the lifetime prevalence of physician-diagnosed atopic eczema in these children. There was also a decrease in the prevalence of atopic eczema symptoms in 13--14 year old children from Kuwait \[from 17.5% (1995--96) to 10.6% (2001--02)\], but the baseline prevalence was much higher [@pone.0039803-Owayed1]. In Israel, the lifetime prevalence of itchy rash in a distribution suggestive of atopic eczema was found to be increasing \[from 5.9% (1997) to 8.7% (2003)\] [@pone.0039803-RomanoZelekha1]. In Turkey, two measures of the prevalence of physician-diagnosed atopic eczema were reported. The lifetime prevalence was stable in 6--13 year old children \[6.1% (1992) and 6.5% (2007)\] [@pone.0039803-Kalyoncu1], whilst the 12-month prevalence was reported to have decreased over a 15-year period in 7--12 year old children \[from 4.0% (1992) to 1.2% (2007)\] [@pone.0039803-Demir1].

The Americas {#s3c}
------------

We found no studies on atopic eczema trends for North America, one study for Central America [@pone.0039803-BarrazaVillarreal1] and four studies for South America [@pone.0039803-Borges1]--[@pone.0039803-Sol1] (see [Table 4](#pone-0039803-t004){ref-type="table"}). No studies reported an incidence trend. The study from Central America, which was conducted in Mexico in 6--8 and 11--14 year old children (see [Table 7](#pone-0039803-t007){ref-type="table"}) [@pone.0039803-BarrazaVillarreal1]. This study showed a sharply decreasing lifetime (and 12-month) prevalence of itchy rash in both age groups \[e.g. in 6--8 year olds -- from 15.0% (1995) to 7.3% (2002)\] and, conversely, a from low baseline increasing lifetime prevalence of physician-diagnosed atopic eczema in both age groups \[e.g. in 6--8 year olds -- from 3.9% (1995) to 6.1% (2002)\].

10.1371/journal.pone.0039803.t007

###### Good and moderate quality studies reporting the prevalence of parental- or self-report of atopic eczema between 1990 and 2010 in the Americas.

![](pone.0039803.t007){#pone-0039803-t007-7}

  Study                                                                            Geographic area              Age range                              Outcome                                  Time period      Baseline estimate    Final estimate     Summary measures     Conclusion              Quality                                                  
  -------------------------------------------------------------------- --------------------------------------- ----------- ---------------------------------------------------------------- ------------------- ------------------- ------------------- ------------------ ---------------- ---------------------------- ------------------------------------- ----------
  **Central America** [\*](#nt110){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                        
  *Measures of symptoms of atopic eczema*                                                                                                                                                                                                                                                                                                                      
  Barraza-villareal et al. (2007) [@pone.0039803-BarrazaVillarreal1]             Mexico (Cuernavaca)              6--8                     ISAAC-based parental-report of:                       1995/2002             2,770                                  2,633                                                                                               Good
                                                                                                                                     lifetime prevalence of dry itchy skin spots                                                     15.0 (13.8--16.4)                      7.3 (6.3--8.4)           P = 0.000                         Decrease                
                                                                                                                                     12-month prevalence of dry itchy skin spots                                                     10.1 (9.1--11.3)                       5.8 (4.9--6.8)           P = 0.000                         Decrease                
  Barraza-villareal et al. (2007) [@pone.0039803-BarrazaVillarreal1]             Mexico (Cuernavaca)             11--14                    ISAAC-based parental-report of:                       1995/2002             2,795                                  2,605                                                                                               Good
                                                                                                                                     lifetime prevalence of dry itchy skin spots                                                     17.0 (15.6--18.4)                      7.0 (6.0--8.1)           P = 0.000                         Decrease                
                                                                                                                                     12-month prevalence of dry itchy skin spots                                                     10.5 (9.5--11.7)                       5.4 (4.5--6.3)           P = 0.000                         Decrease                
  *Measures of physician-diagnosed atopic eczema*                                                                                                                                                                                                                                                                                                              
  Barraza-villareal et al. (2007) [@pone.0039803-BarrazaVillarreal1]             Mexico (Cuernavaca)              6--8                     ISAAC-based parental-report of:                       1995/2002             2,770                                  2,633                                                                                               Good
                                                                                                                               lifetime prevalence of physician-diagnosed atopic eczema                                               3.9 (3.2--4.7)                        6.1 (5.2--7.2)           P = 0.000                         Increase                
  Barraza-villareal et al. (2007) [@pone.0039803-BarrazaVillarreal1]             Mexico (Cuernavaca)             11--14                    ISAAC-based parental-report of:                       1995/2002             2,795                                  2,605                                                                                               Good
                                                                                                                               lifetime prevalence of physician-diagnosed atopic eczema                                               4.2 (3.5--5.0)                        6.9 (6.0--8.0)           P = 0.000                         Increase                
  **South America** [\*](#nt110){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                          
  *Measures of symptoms of atopic eczema*                                                                                                                                                                                                                                                                                                                      
  Camelo-Nunes et al. (2004) [@pone.0039803-CameloNunes1]                        Brazil (São Paulo)               6--7                     ISAAC-based parental-report of:                       1996/1999             3,005                                  3,033                                                                                             Moderate
                                                                                                                                          lifetime prevalence of itchy rash                                                                13.6                                  15.0           P = not significant                     Stable                 
                                                                                                                                     lifetime prevalence of lesions in skin-folds                                                           7.5                                  6.6            P = not significant                     Stable                 
                                                                                                                                          12-month prevalence of itchy rash                                                                10.6                                  9.9            P = not significant                     Stable                 
  Camelo-Nunes et al. (2004) [@pone.0039803-CameloNunes1]                        Brazil (São Paulo)              13--14                      ISAAC-based self-report of:                         1996/1999             3,008                                  3,487                                                                                             Moderate
                                                                                                                                          lifetime prevalence of itchy rash                                                                12.6                                  14.0           P = not significant                     Stable                 
                                                                                                                                     lifetime prevalence of lesions in skin-folds                                                           4.8                                  4.6            P = not significant                     Stable                 
                                                                                                                                          12-month prevalence of itchy rash                                                                 8.1                                  8.8            P = not significant                     Stable                 
  Borges et al. (2008) [@pone.0039803-Borges1]                          Brazil (Federal district of Brasilia)    13--14                      ISAAC-based self-report of:                         1996/2002             3,254                                  3,009                                                                                             Moderate
                                                                                                                                          lifetime prevalence of itchy rash                                                                15.5                                  16.8                P = 0.185                          Stable                 
                                                                                                                                          12-month prevalence of itchy rash                                                                 9.2                                  10.2                P = 0.202                          Stable                 
  Solé et al (2007) [@pone.0039803-Sol1]                                         Brazil (5 centres)              13--14                      ISAAC-based self-report of:                     1994--95/2001--03        15,419                                  15,684                                OR (95% CI)                                                 Moderate
                                                                                                                                          12-month prevalence of itchy rash                                                                10.3                                  8.4         0.80 (0.74--0.86), P\<0.05   Decrease, not uniform among centres  
  Riedi et al. (2005) [@pone.0039803-Riedi1]                                      Brazil (Curitiba)              13--14                      ISAAC-based self-report of:                         1995/2001             3,008                                  3,628                                                                                             Moderate
                                                                                                                                          12-month prevalence of Itchy rash                                                                 6.3                                  6.0            P = not significant                     Stable                 
                                                                                                                            12-month prevalence of Intermittent itchy rash in skin creases                                                  3.7                                  3.7            P = not significant                     Stable                 
  *Measures of physician-diagnosed atopic eczema*                                                                                                                                                                                                                                                                                                              
  Camelo-Nunes et al. (2004) [@pone.0039803-CameloNunes1]                        Brazil (São Paulo)               6--7                     ISAAC-based parental-report of:                       1996/1999             3,005                                  3,033                                                                                             Moderate
                                                                                                                               lifetime prevalence of physician-diagnosed atopic eczema                                                    13.2                                  11.4                 P\<0.05                          Decrease                
  Camelo-Nunes et al. (2004) [@pone.0039803-CameloNunes1]                        Brazil (São Paulo)              13--14                    ISAAC-based parental-report of:                       1996/1999             3,008                                  3,487                                                                                             Moderate
                                                                                                                               lifetime prevalence of physician-diagnosed atopic eczema                                                    14.0                                  15.0           P = not significant                     Stable                 
  Borges et al. (2008) [@pone.0039803-Borges1]                          Brazil (Federal district of Brasilia)    13--14                      ISAAC-based self-report of:                         1996/2002             3,254                                  3,009                                                                                             Moderate
                                                                                                                               lifetime prevalence of physician-diagnosed atopic eczema                                                     9.8                                  13.6                P = 0.0002                        Decrease                
  Solé et al (2007) [@pone.0039803-Sol1]                                         Brazil (5 centres)              13--14                      ISAAC-based self-report of:                     1994--95/2001--03        15,419                                  15,684                                OR (95% CI)                                                 Moderate
                                                                                                                               lifetime prevalence of physician-diagnosed atopic eczema                                                     5.3                                  4.5         0.84 (0.76--0.93), P\<0.05   Decrease, not uniform among centres  

Abbreviations -- CI: confidence intervals, SE: standard error, OR: odds ratio.

Based on UN classification [@pone.0039803-United1].

95% CI and SE are only reported if included in original report.

All four studies from South America were from Brazil and each study included only trends in prevalence as based on parental- or self-report by questionnaires (see [Table 7](#pone-0039803-t007){ref-type="table"}) [@pone.0039803-Borges1]--[@pone.0039803-Sol1]. Two studies measured the lifetime prevalence of atopic eczema symptoms and showed a stable trend among 6--7 and 13--14 year olds \[e.g. itchy rash in São Paulo in 6--7 year olds - 13.6% (1996) and 15.0% (1999)\] [@pone.0039803-Borges1], [@pone.0039803-CameloNunes1]. In another study, the 12-month prevalence of itchy rash remained stable in children aged 13--14 years old \[6.3% (1995) and 6.0% (2001)\] [@pone.0039803-Riedi1], whereas in the last study both the lifetime prevalence of physician-diagnosed atopic eczema and the 12-month prevalence of atopic eczema symptoms were decreasing in 13--14 year olds across five centres \[e.g. physician-diagnosed atopic eczema - from 5.3% (1994--95) to 4.5% (2001--03)\] [@pone.0039803-Sol1].

Europe {#s3d}
------

The largest set of reports (n = 31) on atopic eczema trends is for Europe. The majority of all trends were increasing, although decreasing and stable trends were found in some areas (see [Table 4](#pone-0039803-t004){ref-type="table"}).

### Incidence {#s3d1}

Three studies reported on incidence trends in atopic eczema in Europe [@pone.0039803-Olesen1]--[@pone.0039803-Simpson1]. In Denmark, the adjusted cumulative incidence of the UK Working Party-based parental-report of physician-diagnosed atopic eczema in 7 year olds was 18.9% in 1993 and 19.6% in 1998 (see [Table 8](#pone-0039803-t008){ref-type="table"}). Compared to the survey of 1993 the sample size was over nine times larger in the survey of 1998 [@pone.0039803-Olesen1]. Further, the cumulative incidence of parental-report of history of physician-diagnosed atopic eczema in 5--6 year olds was stable in West Germany \[12.5% (1991) and 12.8% (1997)\], whilst it increased sharply in East Germany \[from 9.6% (1991) to 23.4% (1997)\] [@pone.0039803-Schafer1]. Finally, the age- and sex-standardised incidence of physicians' recorded atopic eczema diagnosis as based on secondary analysis of QRESEARCH, a large primary care dataset (n = 333,294) in England, increased from 9.6% (2001) to 13.6% (2005) per 1000 patient-years [@pone.0039803-Simpson1].

10.1371/journal.pone.0039803.t008

###### Good and moderate quality studies reporting the incidence of parental- or self-report of atopic eczema between 1990 and 2010 in Europe.

![](pone.0039803.t008){#pone-0039803-t008-8}

  Study                                             Geographic area   Age range                                             Outcome                                              Time period   Baseline estimate   Final estimate   Summary measures      Conclusion            Quality                  
  ------------------------------------------------ ----------------- ----------- ---------------------------------------------------------------------------------------------- ------------- ------------------- ---------------- ------------------ ------------------- ------------------- ---------- ----------
  Schäfer et al. (2000) [@pone.0039803-Schafer1]    Germany (west)      5--6                                          Parental-report of:                                         1991/1997          4,001                               4,001                              No formal test                Moderate
                                                                                              cumulative incidence of history of physician-diagnosed atopic eczema                                                      12.5                                 12.8                               Stable   
  Schäfer et al. (2000) [@pone.0039803-Schafer1]    Germany (east)      5--6                                          Parental-report of:                                         1991/1997                                                                                 No formal test                Moderate
                                                                                              cumulative incidence of history of physician-diagnosed atopic eczema                                                      16.0                                 23.4                              Increase  
  Olesen et al. (2005) [@pone.0039803-Olesen1]          Denmark           7                                UK working party-based parental-report of:                             1993/1998          1,060                               9,744                                                            Moderate
                                                                                             adjusted cumulative incidence of physician-diagnosed atopic dermatitis                                                     18.9                                 19.6           No formal test      Stable   
  Simpson et al. (2009) [@pone.0039803-Simpson1]          UK             all                                 QRESEARCH-based physicians' recorded:                                2001--05      \>30 million py                     \>30 million py                        Relative % Change              Moderate
                                                                                  age- and sex-standardised incidence of atopic eczema diagnosis (per 1000 patient years (py))                                     9.6 (9.5--9.7)                      13.6 (13.5--13.7)    41.8, P\<0.001     Increase  

Abbreviations -- CI: confidence intervals, SE: standard error.

Based on UN classification [@pone.0039803-United1].

95% CI and SE are only reported if included in original report.

### Prevalence {#s3d2}

Prevalence data on trends in atopic eczema for western Europe are shown in [Table 9](#pone-0039803-t009){ref-type="table"} [@pone.0039803-Schafer1], [@pone.0039803-AnnesiMaesano1]--[@pone.0039803-Weber1]. Parental- and self-report of atopic eczema symptoms were reported in five countries [@pone.0039803-AnnesiMaesano1], [@pone.0039803-Grize1], [@pone.0039803-Krmer1], [@pone.0039803-Maziak1], [@pone.0039803-Vellinga1], [@pone.0039803-Weber1]. The lifetime prevalence of atopic eczema symptoms increased in 5--7 year old children in Switzerland \[from 11.7% (1992) to 17.4% (2001)\] [@pone.0039803-Grize1] and in slightly older children (aged 6--9) in Austria, but from a lower baseline \[from 9.2% (1995--97) to 11.0% (2001--03)\] [@pone.0039803-Weber1]. This lifetime prevalence of atopic eczema symptoms also increased in Belgium, both in boys and girls aged 6--7 \[e.g. in boys - from 12.9% (1995--96) to 18.4% (2002)\], whilst in 13--14 year old boys and girls it remained stable \[e.g. in boys −15.7% (1995--96) and 13.3% (2002)\] [@pone.0039803-Vellinga1]. We found no data on the lifetime prevalence of atopic eczema symptoms for Germany and France. In France, the lifetime prevalence of physician-diagnosed atopic eczema increased in 13--14 year olds \[from 25.8% (1995) to 30.4% (2002)\] [@pone.0039803-AnnesiMaesano1]. In Germany (Münster), this prevalence also increased in 13--14 year olds \[e.g. in boys - from 8.2% (1994--95) to 10.9% (1999--2000)\], whilst it showed a stable trend in 6--7 year olds \[e.g. in boys −14.3% (1994--95) and 13.6% (1999--2000)\] [@pone.0039803-Maziak1].

10.1371/journal.pone.0039803.t009

###### Good and moderate quality studies reporting the incidence and prevalence of parental- or self-report of atopic eczema between 1990 and 2010 in Europe.

![](pone.0039803.t009){#pone-0039803-t009-9}

  Study                                                                  Geographic area          Age range                                             Outcome                                                   Time period        Baseline estimate              Final estimate              Summary measures                Conclusion                                Quality                              
  -------------------------------------------------------------- ------------------------------- ----------- ---------------------------------------------------------------------------------------------- ----------------------- ------------------- -------------------------------------- ------------------ -------------------------------------- ------------------------------------------ ---------- ----------
  **Western Europe** [\*](#nt116){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                                                         
  *Measures of symptoms of atopic eczema*                                                                                                                                                                                                                                                                                                                                                                      
  Grize et al. (2006) [@pone.0039803-Grize1]                               Switzerland              5--7                                    ISAAC-based parental-report of:                                        1992/2001                988                                                      1,274                                                                                                        Good
                                                                                                                                       adjusted lifetime prevalence of skin rash                                                                                   11.7 (9.7--14.0)                                         17.4 (15.3--19.7)                            P = 0.0014                  Increase  
                                                                                                                            adjusted 12-month prevalence of atopic eczema specific skin rash                                                                        4.6 (3.4--6.2)                                            7.6 (6.2--9.2)                             P = 0.0090                  Increase  
  Vellinga et al. (2005) [@pone.0039803-Vellinga1]                      Belgium (Antwerp)           6--7                                    ISAAC-based parental-report of:                                      1995--96/2002                                                                                                                                          POR (95% CI)                              Good
                                                                                                                                          lifetime prevalence of rash in boys                                                              2,313                         12.9                        2,225                         18.4                           1.5 (1.3--1.8), P = 0.00           Increase  
                                                                                                                                          lifetime prevalence of rash in girls                                                             2,359                         15.7                        2,196                         19.8                           1.3 (1.1--1.5), P = 0.00           Increase  
                                                                                                                                          12-month prevalence of rash in boys                                                              2,313                         8.5                         2,225                         11.4                           1.4 (1.1--1.7), P = 0.00           Increase  
                                                                                                                                          12-month prevalence of rash in girls                                                             2,359                         11.9                        2,196                         14.7                           1.3 (1.1--1.5), P = 0.01           Increase  
  Vellinga et al. (2005) [@pone.0039803-Vellinga1]                      Belgium (Antwerp)          13--14                                   ISAAC-based parental-report of:                                      1995--96/2002                                                                                                                                          POR (95% CI)                              Good
                                                                                                                                          lifetime prevalence of rash in boys                                                              1,240                         15.7                        1,215                         13.3                           0.9 (0.7--1.1), P = 0.17            Stable   
                                                                                                                                          lifetime prevalence of rash in girls                                                             1,150                         19.0                        1,318                         20.3                           1.1 (0.9--1.3), P = 0.30            Stable   
                                                                                                                                          12-month prevalence of rash in boys                                                              1,240                         9.7                         1,215                         8.5                            0.9 (0.7--1.1), P = 0.30            Stable   
                                                                                                                                          12-month prevalence of rash in girls                                                             1,150                         13.3                        1,318                         13.6                           1.0 (0.8--1.3), P = 0.84            Stable   
  Krämer et al. (2009) [@pone.0039803-Krmer1]                            Germany (west)               6                                     ISAAC-based parental-report of:                                   1994--95/1996--2000          4,761                                                     3,654                                                          Area-adjusted trend                           Good
                                                                                                                                         12-month prevalence of itchy skin rash                                                                                          4.6                                                       4.5                               0.89 (0.41--1.92)                Stable   
  Krämer et al. (2009) [@pone.0039803-Krmer1]                            Germany (east)               6                                     ISAAC-based parental-report of:                                   1994--95/1996--2000         114,457                                                    9,031                                                          Area-adjusted trend                           Good
                                                                                                                                         12-month prevalence of itchy skin rash                                                                                          6.3                                                       6.2                               0.96 (0.66--1.39)                Stable   
  Maziak et al. (2003) [@pone.0039803-Maziak1]                          Germany (Münster)           6--7                                    ISAAC-based parental-report of:                                   1994--95/1999--2000                                                                                                                                       POR (95% CI)                              Good
                                                                                                                                 12-month prevalence of atopic eczema symptoms in boys                                                     1,754                         7.3                         1,863                         6.6                                0.9 (0.69--1.17)                Stable   
                                                                                                                                 12-month prevalence of atopic eczema symptoms in girls                                                    1,713                         6.7                         1,666                         9.8                                1.5 (1.18--1.97)               Increase  
  Maziak et al. (2003) [@pone.0039803-Maziak1]                          Germany (Münster)          13--14                                     ISAAC-based self-report of:                                     1994--95/1999--2000                                                                                                                                       POR (95% CI)                              Good
                                                                                                                                 12-month prevalence of atopic eczema symptoms in boys                                                     1,865                         5.0                         1,894                         4.5                                0.9 (0.66--1.22)                Stable   
                                                                                                                                 12-month prevalence of atopic eczema symptoms in girls                                                    1,892                         9.4                         1,922                         11.1                               1.2 (0.98--1.50)                Stable   
  Weber et al. (2010) [@pone.0039803-Weber1]                             Austria (Upper)            6--9                                    ISAAC-based parental-report of:                                    1995--97/2001--03          12,115                                                     11,468                                                            No formal test                           Moderate
                                                                                                                                              lifetime prevalence of rash                                                                                                9.2                                                       11.0                                                              Increase  
                                                                                                                                              12-month prevalence of rash                                                                                                6.0                                                       6.7                                                                Stable   
  Annesi-Maesano et al. (2009) [@pone.0039803-AnnesiMaesano1]     France (Languedoc Roussillon)    13--14                                     ISAAC-based self-report of:                                          1995/2002               3,383                                                     1,642                                                       Absolute/relative % Change                     Moderate
                                                                                                                                     12-month prevalence of atopic eczema symptoms                                                                                       12.5                                                      14.3                        1.78/0.14, P = not significant         Stable   
  *Measures of physician-diagnosed atopic eczema*                                                                                                                                                                                                                                                                                                                                                              
  Grize et al. (2006) [@pone.0039803-Grize1]                               Switzerland              5--7                                    ISAAC-based parental-report of:                                        1992/2001                988                                                      1,274                                                                                                        Good
                                                                                                                           adjusted lifetime prevalence of physician-diagnosed atopic eczema                                                                      18.4 (15.8--21.2)                                         15.2 (13.2--17.4)                         P trend = 0.1065                Stable   
  Vellinga et al. (2005) [@pone.0039803-Vellinga1]                      Belgium (Antwerp)           6--7                                    ISAAC-based parental-report of:                                      1995--96/2002                                                                                                                                          POR (95% CI)                              Good
                                                                                                                                       lifetime prevalence atopic eczema in boys                                                           2,313                         18.5                        2,225                         20.8                           1.2(1.0--1.3), P = 0.06            Increase  
                                                                                                                                       lifetime prevalence atopic eczema in girls                                                          2,359                         19.1                        2,196                         22.4                           1.2(1.1--1.4), P = 0.01            Increase  
  Vellinga et al. (2005) [@pone.0039803-Vellinga1]                      Belgium (Antwerp)          13--14                                   ISAAC-based parental-report of:                                      1995--96/2002                                                                                                                                          POR (95% CI)                              Good
                                                                                                                                       lifetime prevalence atopic eczema in boys                                                           1,240                         23.4                        1,215                         21.1                           0.9(0.7--1.1), P = 0.17             Stable   
                                                                                                                                       lifetime prevalence atopic eczema in girls                                                          1,150                         27.8                        1,318                         29.7                           1.1(0.9--1.3), P = 0.30             Stable   
  Schäfer et al. (2000) [@pone.0039803-Schafer1]                         Germany (west)             5--6                                               Report of:                                                  1991/1997                801                                                       771                                                              No formal test                           Moderate
                                                                                                                                current prevalence of physician-diagnosed atopic eczema                                                                                  11.2                                                      4.5                                                               Decrease  
  Schäfer et al. (2000) [@pone.0039803-Schafer1]                         Germany (east)             5--6                                               Report of:                                                  1991/1997                285                                                       633                                                              No formal test                           Moderate
                                                                                                                                current prevalence of physician-diagnosed atopic eczema                                                                                  17.5                                                      11.2                                                              Decrease  
  Krämer et al. (2009) [@pone.0039803-Krmer1]                            Germany (west)               6                                                Report of:                                             1991--95/1996--2000          4,761                                                     3,654                                                       Area-adjusted trend (10 y)                       Good
                                                                                                                                current prevalence of physician-diagnosed atopic eczema                                                                                  10.5                                                      5.2                               0.30 (0.17--0.53)               Decrease  
  Krämer et al. (2009) [@pone.0039803-Krmer1]                            Germany (east)               6                                                Report of:                                            1991--1995/1996--2000        114,457                                                    9,031                                                       Area-adjusted trend (10 y)                       Good
                                                                                                                                current prevalence of physician-diagnosed atopic eczema                                                                                  14.3                                                      10.5                              0.36 (0.17--0.61)               Decrease  
  Maziak et al. (2003) [@pone.0039803-Maziak1]                          Germany (Münster)           6--7                                    ISAAC-based parental-report of:                                   1994--95/1999--2000                                                                                                                                       POR (95% CI)                              Good
                                                                                                                            lifetime prevalence of physician-diagnosed atopic eczema in boys                                               1,754                         14.3                        1,863                         13.6                               0.9 (0.77--1.13)                Stable   
                                                                                                                           lifetime prevalence of physician-diagnosed atopic eczema in girls                                               1,713                         14.6                        1,666                         16.9                               1.2 (0.99--1.44)                Stable   
  Maziak et al. (2003) [@pone.0039803-Maziak1]                          Germany (Münster)          13--14                                   ISAAC-based parental-report of:                                   1994--95/1999--2000                                                                                                                                       POR (95%CI)                               Good
                                                                                                                            lifetime prevalence of physician-diagnosed atopic eczema in boys                                               1,865                         8.2                         1,894                         10.9                               1.4 (1.09--1.71)               Increase  
                                                                                                                           lifetime prevalence of physician-diagnosed atopic eczema in girls                                               1,892                         12.3                        1,922                         17.4                               1.5 (1.22--1.77)               Increase  
  Heinrich et al. (2002) [@pone.0039803-Heinrich1]                       Germany (east)                                                           Parental-report of:                                        1992--1993/1998--1999         2,773                                                     3,092                                                             No formal test                           Moderate
                                                                                                      6                    adjusted lifetime prevalence of physician-diagnosed atopic eczema                                                                             8.6                                                       13.0                                                              Increase  
                                                                                                      9                    adjusted lifetime prevalence of physician-diagnosed atopic eczema                                                                             8.6                                                       11.8                                                              Increase  
                                                                                                     12                    adjusted lifetime prevalence of physician-diagnosed atopic eczema                                                                             9.6                                                       10.2                                                              Increase  
  Schernhammer et al. (2008) [@pone.0039803-Schernhammer1]               Austria (Upper)            6--7                                    ISAAC-based parental-report of:                                    1995--97/2001--03          13,399                                                     12,784                                                                                                     Moderate
                                                                                                                                lifetime prevalence of physician-diagnosed atopic eczema                                                                                 10.1                                                      13.8                                   P\<0.001                   Increase  
  Haidinger et al. (2008) [@pone.0039803-Haidinger1]                     Austria (Upper)            6--7                                    ISAAC-based parental-report of:                                    1995--97/2001--03          35,238                                                     12,541                                                              \% Change                              Moderate
                                                                                                                                lifetime prevalence of physician-diagnosed atopic eczema                                                                                 9.9                                                       13.6                                     3.7                      Increase  
  Weber et al. (2010) [@pone.0039803-Weber1]                             Austria (Upper)            6--9                                    ISAAC-based parental-report of:                                    1995--97/2001--03          12,115                                                     11,468                                                            No formal test                           Moderate
                                                                                                                              lifetime prevalence of physician-diagnosed atopic dermatitis                                                                               9.6                                                       13.4                                                              Increase  
  Schernhammer et al. (2008) [@pone.0039803-Schernhammer1]               Austria (Upper)           12--14                                     ISAAC-based self-report of:                                      1995--97/2001--03           1,516                                                     1,443                                                                                                      Moderate
                                                                                                                                lifetime prevalence of physician-diagnosed atopic eczema                                                                                 6.3                                                       12.1                                   P\<0.001                   Increase  
  Annesi-Maesano et al. (2009) [@pone.0039803-AnnesiMaesano1]     France (Languedoc Roussillon)    13--14                                     ISAAC-based self-report of:                                          1995/2002               3,383                                                     1,642                                                       Absolute/relative % Change                     Moderate
                                                                                                                              lifetime prevalence of physician-diagnosed atopic dermatitis                                                                               25.8                                                      30.4                             4.56/0.17, P = 0.001             Increase  
  **Southern Europe** [\*](#nt116){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                                                        
  *Measures of symptoms of atopic eczema*                                                                                                                                                                                                                                                                                                                                                                      
  Montefort et al. (2009) [@pone.0039803-Montefort1]                     Maltese Islands            5--8                                    ISAAC-based parental-report of:                                    1994--95/2001--02           4,465                                                     4,761                                                                                                      Moderate
                                                                                                                                         lifetime prevalence of recurrent rash                                                                                           7.0                                                       6.7                                    P = 0.61                    Stable   
                                                                                                                                         12-month prevalence of recurrent rash                                                                                           5.5                                                       5.4                                    P = 0.85                    Stable   
  Galassi et al. (2006) [@pone.0039803-Galassi1]                          Italy (North)             6--7                                    ISAAC-based parental-report of:                                      1994--95/2002            16,115                                                     11,287                                               Area-adjusted absolute % Change (95% CI)                Good
                                                                                                                                     12-month prevalence of atopic eczema symptoms                                                                                       8.3                                                       14.5                                6.2 (5.3--7.1)                Increase  
                                                                                                                               12-month prevalence of atopic eczema symptoms in flexures                                                                                 6.0                                                       10.4                                4.4 (3.6--5.2)                Increase  
  Galassi et al. (2006) [@pone.0039803-Galassi1]                          Italy (North)            13--14                                     ISAAC-based self-report of:                                        1994--95/2002            19,723                                                     10,267                                               Area-adjusted absolute % Change (95% CI)                Good
                                                                                                                                     12-month prevalence of atopic eczema symptoms                                                                                       10.1                                                      11.2                                1.2 (0.1--2.4)                Increase  
                                                                                                                               12-month prevalence of atopic eczema symptoms in flexures                                                                                 6.5                                                       8.5                                 2.1 (1.2--3.0)                Increase  
  Anthracopoulos et al. (2009) [@pone.0039803-Anthracopoulos1]           Greece (Patras)            8--10                                         Parental-report of:                                              1991/2003               2,417                                                     2,725                                                                                                      Moderate
                                                                                                                                     lifetime prevalence of atopic eczema symptoms                                                                                       4.5                                                       9.5                                P trend \<0.001                Increase  
                                                                                                                                     24-month prevalence of atopic eczema symptoms                                                                                       2.5                                                       5.0                                P trend \<0.001                Increase  
  *Measures of physician-diagnosed atopic eczema*                                                                                                                                                                                                                                                                                                                                                              
  Montefort et al. (2009) [@pone.0039803-Montefort1]                     Maltese Islands            5--8                                    ISAAC-based parental-report of:                                    1994--95/2001--02           4,465                                                     4,761                                                                                                      Moderate
                                                                                                                                lifetime prevalence of physician-diagnosed atopic eczema                                                                                 4.4                                                       11.2                                  P\<0.0001                   Increase  
  Galassi et al. (2006) [@pone.0039803-Galassi1]                          Italy (North)             6--7                                    ISAAC-based parental-report of:                                      1994--95/2002            16,115                                                     11,287                                               Area-adjusted absolute % Change (95% CI)                Good
                                                                                                                                          lifetime prevalence of atopic eczema                                                                                           14.3                                                       17                                 2.5 (1.6--3.5)                Increase  
  Galassi et al. (2006) [@pone.0039803-Galassi1]                          Italy (North)            13--14                                   ISAAC-based parental-report of:                                      1994--95/2002            19,723                                                     9,362                                                Area-adjusted absolute % Change (95% CI)                Good
                                                                                                                                          lifetime prevalence of atopic eczema                                                                                           11.0                                                      12.8                                1.5 (0.3--2.8)                Increase  
  Rosado-Pinto et al. (2006) [@pone.0039803-Rosadopinto1]                   Portugal                6--7                                         ISAAC-based report of:                                          1993--94/2002             5,000                                                     5,350                                                                                                      Moderate
                                                                                                                                          lifetime prevalence of atopic eczema                                                                                           18.6                                                      21.0                                  P = 0.002                   Increase  
                                                                                                                                          12-month prevalence of atopic eczema                                                                                           13.9                                                      15.6                                  P = 0.013                   Increase  
  Rosado-Pinto et al. (2006) [@pone.0039803-Rosadopinto1]                   Portugal               13--14                                        ISAAC-based report of:                                          1993--94/2002            11,400                                                     11,850                                                                                                     Moderate
                                                                                                                                          lifetime prevalence of atopic eczema                                                                                           12.8                                                      13.3                                   P = 0.22                    Stable   
                                                                                                                                          12-month prevalence of atopic eczema                                                                                           7.6                                                       8.7                                   P = 0.002                   Increase  
  **Northern Europe** [\*](#nt116){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                                                        
  *Measures of symptoms of atopic eczema*                                                                                                                                                                                                                                                                                                                                                                      
  Annus et al. (2005) [@pone.0039803-Annus1]                            Estonia (Tallinn)           6--7                                    ISAAC-based parental-report of:                                    1993--94/2001--02           3,070                                                     2,383                                                       Sex-adjusted POR (95% CI)                        Good
                                                                                                                                           lifetime prevalence of itchy rash                                                                                             16.9                                                      22.0                         1.40 (1.22--1.61), P\<0.001          Increase  
                                                                                                                                           12-month prevalence of itchy rash                                                                                             12.6                                                      17.1                         1.44 (1.24--1.67), P\<0.001          Increase  
                                                                                                                                          12-month prevalence of flexural rash                                                                                           12.0                                                      13.5                         1.20 (1.02--1.41), P = 0.025         Increase  
  Annus et al. (2005) [@pone.0039803-Annus1]                            Estonia (Tallinn)          13--14                                   ISAAC-based parental-report of:                                    1993--94/2001--02           3,476                                                     3,576                                                       Sex-adjusted POR (95% CI)                        Good
                                                                                                                                           lifetime prevalence of itchy rash                                                                                             15.2                                                      19.3                         1.34 (1.18--1.52), P\<0.001          Increase  
                                                                                                                                           12-month prevalence of itchy rash                                                                                             10.4                                                      14.9                         1.51 (1.31--1.74), P\<0.001          Increase  
                                                                                                                                          12-month prevalence of flexural rash                                                                                           7.7                                                       9.4                          1.26 (1.07--1.50), P = 0.006         Increase  
  Shamssain et al. (2007) [@pone.0039803-Shamssain1]                 UK (North-east England)        6--7                                    ISAAC-based parental-report of:                                    1995--96/2001--02           3,000                                                     1,843                                                              OR (95% CI)                               Good
                                                                                                                                          lifetime prevalence of rash in boys                                                                                            17.8                                                      21.0                               1.6 (1.29--1.98)               Increase  
                                                                                                                                          lifetime prevalence of rash in girls                                                                                           18.7                                                      22.5                               1.8(1.35--2.30)                Increase  
                                                                                                                             lifetime prevalence of rash with typical distribution in boys                                                                               13.2                                                      21.1                               1.9 (1.41--3.57)               Increase  
                                                                                                                             lifetime prevalence of rash with typical distribution in girls                                                                              14.7                                                      23.8                               1.8(1.35--2.25)                Increase  
                                                                                                                                      12-month prevalence of current rash in boys                                                                                        14.7                                                      23.3                               1.4 (1.31--1.61)               Increase  
                                                                                                                                      12-month prevalence of current rash in girls                                                                                       16.9                                                      25.0                               1.8(1.42--2.28)                Increase  
  Shamssain et al. (2007) [@pone.0039803-Shamssain1]                 UK (North-east England)       13--14                                   ISAAC-based parental-report of:                                    1995--96/2001--02           3,000                                                     2,195                                                              OR (95% CI)                               Good
                                                                                                                                          lifetime prevalence of rash in boys                                                                                            13.9                                                      15.3                               1.1 (0.88--1.22)                Stable   
                                                                                                                                          lifetime prevalence of rash in girls                                                                                           22.8                                                      17.5                               1.6 (1.29--1.98)               Increase  
                                                                                                                             lifetime prevalence of rash with typical distribution in boys                                                                               8.8                                                       19.6                               2.4 (1.81--3.37)               Increase  
                                                                                                                             lifetime prevalence of rash with typical distribution in girls                                                                              15.9                                                      19.3                               1.5 (1.12--1.98)               Increase  
                                                                                                                                      12-month prevalence of current rash in boys                                                                                        11.3                                                      16.8                               1.6 (1.30--2.20)               Increase  
                                                                                                                                      12-month prevalence of current rash in girls                                                                                       20.5                                                      20.9                               1.0 (0.89--1.32)                Stable   
  Anderson et al. (2004) [@pone.0039803-Anderson1]                     UK (British Isles)          12--14                                     ISAAC-based self-report of:                                          1995/2002              15,083                                                     15,755                                                      Absolute/Relative % Change                     Moderate
                                                                                                                                          12-month prevalence of flexural rash                                                                                           16.2                                                      11.4                                 --4.8/−29.6                  Decrease  
  Bjerg et al. (2010) [@pone.0039803-Bjerg1]                      Sweden (Kiruna, Luleå, Piteå)     7--8                                    ISAAC-based parental-report of:                                        1996/2006               3,430                                                     2,585                                                                                                        Good
                                                                                                                                     12-month prevalence of atopic eczema symptoms                                                                                       27.2                                                      25.8                                  P = 0.215                    Stable   
  Rönmark et al. (2009) [@pone.0039803-Ronmark1]                        Sweden (northern)           7--8                                    ISAAC-based parental-report of:                                        1996/2006               2,148                                                     1,700                                                                                                      Moderate
                                                                                                                                     lifetime prevalence of atopic eczema symptoms                                                                                       29.3                                                      26.5                                  P = 0.048                   Decrease  
  Kudzytė et al. (2008) [@pone.0039803-Kudzyt1]                        Lithuania (Kaunas)           6--7                                    ISAAC-based parental-report of:                                    1994--95/2001--02           1,879                                                     2,772                                                                                                      Moderate
                                                                                                                                           12-months prevalence of itchy rash                                                                                            2.6                                                       3.9                                    P\<0.05                    Increase  
  *Measures of physician-diagnosed atopic eczema*                                                                                                                                                                                                                                                                                                                                                              
  Kuehni et al. (2001) [@pone.0039803-Weber1]                          UK (Leicestershire)          1--5                                         Secondary analysis of:                                            1990/1998               1,264                                                     2,127                                                   Age- and sex-adjusted OR (95% CI)                    Good
                                                                                                                          lifetime prevalence of physicians' recorded atopic eczema diagnosis                                                                            29.0                                                      44.0                         1.95 (1.68--2.27), P\<0.001          Increase  
  Shamssain et al. (2007) [@pone.0039803-Shamssain1]                 UK (North-east England)        6--7                                    ISAAC-based parental-report of:                                    1995--96/2001--02                                                                                                                                        OR (95% CI)                               Good
                                                                                                                                      lifetime prevalence of atopic eczema in boys                                                         1,445                         27.8                         918                          37.0                         1.9 (1.45--3.55), P = 0.001          Increase  
                                                                                                                                     lifetime prevalence of atopic eczema in girls                                                         1,545                         27.0                         925                          35.5                         1.8 (1.45--2.45), P = 0.001          Increase  
  Shamssain et al. (2007) [@pone.0039803-Shamssain1]                 UK (North-east England)       13--14                                   ISAAC-based parental-report of:                                    1995--96/2001--02                                                                                                                                        OR (95% CI)                               Good
                                                                                                                                      lifetime prevalence of atopic eczema in boys                                                         1,510                         13.9                        1,000                         27.2                        6.13 (3.52--10.79), P = 0.001         Increase  
                                                                                                                                     lifetime prevalence of atopic eczema in girls                                                         1,490                         22.8                        1,195                         30.7                         1.63 (1.48--1.81), P = 0.001         Increase  
  Ng Man Kwong et al. (2001) [@pone.0039803-NgManKwong1]                 UK (Sheffield)             8--9                                    ISAAC-based parental-report of:                                        1991/1999               4,523                                                     4,809                                                       Absolute % Change (95% CI)                     Moderate
                                                                                                                                          lifetime prevalence of atopic eczema                                                                                           18.1                                                      31.1                        13.0 (11.27--14.72), P\<0.001         Increase  
  Anderson et al. (2004) [@pone.0039803-Anderson1]                     UK (British Isles)          12--14                                     ISAAC-based self-report of:                                          1995/2002              15,083                                                     15,755                                                      Absolute/Relative % Change                     Moderate
                                                                                                                                          lifetime prevalence of atopic eczema                                                                                           21.1                                                      24.3                                   3.3/15.4                   Increase  
  Simpson et al. (2009) [@pone.0039803-Simpson1]                               UK                    all                                         Secondary analysis of:                                           2001--2005            \>9 million                                               \>9 million                                                        Relative % Change                          Moderate
                                                                                                              age-and sex-standardised lifetime prevalence of physicians' recorded atopic eczema diagnosis                                                          7.8 (7.8--7.8)                                          11.5 (11.5--11.6)                          48.2, P\<0.001                Increase  
  McNeill et al. (2009) [@pone.0039803-McNeill1]                       Scotland (Aberdeen)          7--9                                    ISAAC-based parental-report of:                                        1999/2004               2,340                  24.0 (22.3--25.7)                  1,070                  34.6 (32.3--36.9)                          No formal test                Increase   Moderate
                                                                                                                                          lifetime prevalence of atopic eczema                                                                                                                                                                                                                                 
  Osman et al. (2007) [@pone.0039803-Osman1]                           Scotland (Aberdeen)          9--11                                   ISAAC-based parental-report of:                                        1994/2004                                                                                                                                                                                    Moderate
                                                                                                                                      lifetime prevalence of atopic eczema in boys                                                         2,021                         17.9                         935                          23.6                               P trend\<0.0001                Increase  
                                                                                                                                     lifetime prevalence of atopic eczema in girls                                                         2,026                         17.5                         980                          28.9                               P trend\<0.0001                Increase  
  McNeill et al. (2009) [@pone.0039803-McNeill1]                       Scotland (Aberdeen)          9--12                                   ISAAC-based parental-report of:                                        1999/2004               3,280                                                     1,498                                                             No formal test                           Moderate
                                                                                                                                          lifetime prevalence of atopic eczema                                                                                    21.1 (19.7--22.5)                                         34.2 (31.8--36.6)                                                        Increase  
  Devenny et al. (2004) [@pone.0039803-Devenny1]                       Scotland (Aberdeen)          9--12                                   ISAAC-based parental-report of:                                        1994/1999               4,047                                                     3,537                                                              RR (95% CI)                             Moderate
                                                                                                                                          lifetime prevalence of atopic eczema                                                                                           18.0                                                      21.0                               1.2 (1.10--1.33)               Increase  
  Kudzytė et al. (2008) [@pone.0039803-Kudzyt1]                        Lithuania (Kaunas)           6--7                                    ISAAC-based parental-report of:                                    1994--95/2001--02           1,879                                                     2,772                                                                                                      Moderate
                                                                                                                                lifetime prevalence of physician-diagnosed atopic eczema                                                                                 1.4                                                       3.5                                    P\<0.05                    Increase  
  Selnes et al. (2005) [@pone.0039803-Selnes1]                         Norway (subarctic)           9--11                                     ISAAC-based self-report of:                                          1995/2000               1,432                                                     3,853                                                              RR (95% CI)                             Moderate
                                                                                                                                          lifetime prevalence of atopic eczema                                                                                           21.1                                                      20.8                              0.99 (0.88--1.11)                Stable   
  Bjerg et al. (2010) [@pone.0039803-Bjerg1]                      Sweden (Kiruna, Luleå, Piteå)     7--8                                    ISAAC-based parental-report of:                                        1996/2006               3,430                                                     2,585                                                                                                      Moderate
                                                                                                                                lifetime prevalence of physician-diagnosed atopic eczema                                                                                 13.4                                                      15.2                                  P = 0.048                   Increase  
  Latvala et al. (2005) [@pone.0039803-Latvala1]                             Finland               18--19                                              Report of:                                                 1990--2000                --                                                         --                                                              No formal test                           Moderate
                                                                                                                                12-month prevalence of physician-diagnosed atopic eczema                                                                 1.2[\#](#nt118){ref-type="table-fn"}                      1.2[\#](#nt118){ref-type="table-fn"}                                               Stable   
  **Eastern Europe** [\*](#nt116){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                                                         
  *Measures of physician-diagnosed atopic eczema*                                                                                                                                                                                                                                                                                                                                                              
  Harangi et al. (2007) [@pone.0039803-Harangi1]                    Hungary (Baranya County)        7--9                            Hanifin-Rajka criteria-based parental-report of:                               2002/2005                587                                                       574                                                              No formal test                           Moderate
                                                                                                                                         physician-diagnosed atopic dermatitis                                                                                           17.0                                                      17.1                                                               Stable   
  Harangi et al. (2007) [@pone.0039803-Harangi1]                    Hungary (Baranya County)        7--14                           Hanifin-Rajka criteria-based parental-report of:                               2002/2005               1,454                                                     1,454                                                             No formal test                           Moderate
                                                                                                                                         physician-diagnosed atopic dermatitis                                                                                           15.1                                                      16.1                                                               Stable   
  Brożek et al. (2004) [@pone.0039803-Brozek1]                          Poland (Chorzów)            7--10                                         Parental-report of:                                              1993/2002               1,130                                                     1,451                                                                                                      Moderate
                                                                                                                                lifetime prevalence of physician-diagnosed atopic eczema                                                                                 2.3                                                       8.1                                    P\<0.001                   Increase  

Abbreviations -- CI: confidence intervals, SE: standard error, POR: prevalence odds ratio, OR: odds ratio.

Based on UN classification [@pone.0039803-United1].

95% CI and SE are only reported if included in original report.

Point estimate extracted from graph or chart.

In southern Europe, the lifetime prevalence of atopic eczema symptoms remained stable in the Maltese Islands in 5--8 year olds \[7.0% (1994--95) and 6.7% (2001--02)\] [@pone.0039803-Montefort1] and increased in Greece in older children (aged 8--10) \[from 4.5% (1991) to 9.5% (2003)\] [@pone.0039803-Anthracopoulos1]. Here, the trend was measured over a longer time period and started at a lower baseline level. In Italy and Portugal, no lifetime prevalence trends for atopic eczema symptoms were reported. The lifetime prevalence of physician-diagnosed atopic eczema showed an increasing trend in 6--7 year olds in Italy \[from 14.3% (1994--95) to 17.0% (2002)\] [@pone.0039803-Galassi1] and in the same age group in Portugal \[from 18.6% (1993--94) to 21.0% (2002)\] [@pone.0039803-Rosadopinto1]. Compared to Italy and Portugal, the increase of physician-diagnosed atopic eczema in the Maltese Islands in a similar age group of 5--8 year olds was considerably larger and more than doubled over a 7-year period, as it originated from a low baseline \[from 4.4% (1994--95) to 11.2% (2001--02)\] [@pone.0039803-Montefort1].

For northern Europe, 15 papers reported on trends in atopic eczema [@pone.0039803-Olesen1], [@pone.0039803-Simpson1], [@pone.0039803-Anderson1]--[@pone.0039803-Shamssain1]. The prevalence of rash and rash with a typical distribution was overall increasing in boys and girls and in 6--7 and 13--14 year olds in the UK \[e.g. in 6--7 year old boys -- from 17.8% (1995--96) to 21.0% (2001--02)\], although not all trends reached significance [@pone.0039803-Shamssain1]. Several other studies, which measured the lifetime prevalence of physician-diagnosed atopic eczema [@pone.0039803-Anderson1], [@pone.0039803-Devenny1], [@pone.0039803-McNeill1]--[@pone.0039803-Osman1] or the lifetime prevalence of physicians' recorded atopic eczema diagnosis [@pone.0039803-Simpson1], [@pone.0039803-Kuehni1] in the UK, also showed increasing trends confirming patterns of atopic eczema prevalence in the UK in children and across all age-groups over time. An increasing trend for atopic eczema symptoms was also found in Estonia in 6--7 year olds \[from 16.9% (1993--94) to 22.0% (2001--02)\] [@pone.0039803-Annus1]. However, in Sweden in slightly older children (aged 7--8), the lifetime prevalence of atopic eczema symptoms was decreasing \[from 29.3% (1996) to 26.5% (2006)\] [@pone.0039803-Ronmark1]. Despite this decrease, prevalence estimates remained higher as compared to Estonia. There was no data on the lifetime prevalence of atopic eczema symptoms available in Lithuania and Norway. In Lithuania in 6--7 year olds, the prevalence of physician-diagnosed atopic eczema was increasing from an extremely low baseline \[from 1.4% (1994--95) to 3.5% (2002--03)\] [@pone.0039803-Kudzyt1]. In Norway, this prevalence was stable in 9--11 year olds \[21.1% (1995) and 20.8% (2000)\] [@pone.0039803-Selnes1].

Two studies yielded relevant data in relation to eastern Europe. In Poland, the lifetime prevalence of parental-reported physician-diagnosed atopic eczema increase over a decade in children aged 7--10 \[from 2.3% (1993) to 8.1% (2002)\] [@pone.0039803-Brozek1]. Later, this same prevalence, measured with a different questionnaire in both 7--9 and 7--14 year olds, remained stable in Hungary over a relatively short time period \[e.g. for 7--9 year olds --15.1% (2002) and 17.1% (2005)\] [@pone.0039803-Harangi1]. In Europe, there were many other countries with single measurements of any atopic eczema outcome, but serial data were not yet available.

Oceania {#s3e}
-------

For Oceania, we found three papers from Australia with prevalence data on atopic eczema trends (see [Table 4](#pone-0039803-t004){ref-type="table"}) [@pone.0039803-Ponsonby1]--[@pone.0039803-Toelle1]. As shown in [Table 10](#pone-0039803-t010){ref-type="table"}, the lifetime prevalence of atopic eczema symptoms was measured in Melbourne in 6--7 year olds, where it markedly increased from 22.6% in 1993 to 32.3% in 2002 [@pone.0039803-Robertson1]. Two other studies measured trends in lifetime prevalence of atopic eczema diagnosis. In one study this was increasing in 4--6 year olds, even though the baseline prevalence was high \[from 31.0% (2000) to 37.0% (2005)\] [@pone.0039803-Ponsonby1] and in another study, using a non-validated questionnaire, it was stable in 8--11 year olds [@pone.0039803-Toelle1].

10.1371/journal.pone.0039803.t010

###### Good and moderate quality studies reporting the prevalence of parental- or self-report of atopic eczema between 1990 and 2010 in Oceania.

![](pone.0039803.t010){#pone-0039803-t010-10}

  Study                                                            Geographic area                Age range                              Outcome                              Time period   Baseline estimate              Final estimate               Summary measures                Conclusion                               Quality                            
  --------------------------------------------------- ------------------------------------------ ----------- --------------------------------------------------------------- ------------- ------------------- --------------------------------------- ------------------ --------------------------------------- -------------------------------------- ---------- ----------
  *Measures of symptoms of atopic eczema*                                                                                                                                                                                                                                                                                                                           
  Robertson et al. (2004)[@pone.0039803-Robertson1]             Australia (Melbourne)               6--7                     ISAAC-based parental-report of:                   1993/2002          2,843                                                      2,968                                                            No formal test                         Moderate
                                                                                                                      lifetime prevalence of atopic eczema symptoms                                                       22.6 (20.8--24.6)                                          32.3 (30.4--34.2)                                                    Increase  
                                                                                                                      12-month prevalence of atopic eczema symptoms                                                       11.1 (10.0--12.3)                                          17.2 (15.7--18.8)                                                    Increase  
  *Measures of physician-diagnosed atopic eczema*                                                                                                                                                                                                                                                                                                                   
  Ponsonby et al. (2008) [@pone.0039803-Ponsonby1]     Australia (Australian Capital Territory)     4--6      Annual school entry-based and ISAAC-based parental-report of:    2000--05           3,873                                                      3,849                                                    Adjusted OR (95% CI) per year                    Good
                                                                                                                          lifetime prevalence of atopic eczema                                                  31.0[\#](#nt122){ref-type="table-fn"}                      37.0[\#](#nt122){ref-type="table-fn"}        1.05 (1.03--1.07) P\<0.001        Increase  
  Toelle et al. (2004) [@pone.0039803-Toelle1]                   Australia (Belmont)                8--11                    ISAAC-based parental-report of:                   1992/2002           908                                                        800                                                           \% Change (95%CI)                        Moderate
                                                                                                                          lifetime prevalence of atopic eczema                                                                  24.4                                                       24.8                    0.4 (−3.7--4.5), P = not significant    Stable   

Abbreviations -- CI: confidence intervals, SE: standard error, OR: odds ratio.

Based on UN classification [@pone.0039803-United1].

95% CI and SE are only reported if included in original report.

Point estimate extracted from graph or chart.

Discussion {#s4}
==========

The considerable body of international literature identified by this systematic review was heterogeneous in many respects rendering it difficult to directly compare different regions. That said, there was no obvious consistent overall global trend in the incidence or prevalence of atopic eczema symptoms and diagnosis. Nevertheless, in Africa and eastern Asia there was an increasing trend for both the lifetime prevalence of parental- and self-reported atopic eczema symptoms and physician-diagnosed atopic eczema. In western Europe and parts of northern Europe (i.e. the UK), these trends were also mainly increasing. There were extremely diverse trends among different age groups and countries in south-eastern Asia, western Asia and southern Europe. In addition, data for the Americas, eastern Europe and Oceania were limited. The heterogeneous findings in some regions and the limited data available for other regions have precluded conclusions regarding a global atopic eczema trend and atopic eczema trends in major parts of the world.

We found that many outcome measures are used across studies to determine changes in atopic eczema prevalence. Although we found that trends of all outcomes generally pointed in the same direction, we considered the lifetime prevalence of parental- or self-report of atopic eczema symptoms the optimal outcome for the purpose of comparing disease trends between regions within our highly heterogeneous dataset. As atopic eczema occurs in episodes and may be season-related it is particularly difficult to compare studies measuring current or 12-month symptomatology or if patient- and/or study- characteristics, such as age group, do not match. Furthermore, there are marked differences per region in current medical practice, including prevention strategies, national guidelines and physician's awareness of the problem, that make prevalence estimates and trends of physician-diagnosed atopic eczema difficult to compare across the globe. Even though the diagnostic process of a physician is overall likely to be standardised, there is no objective gold standard. This is highlighted in the ENRIECO project which shows that different countries use different terms to describe atopic eczema [@pone.0039803-Galassi2]. In addition, not every language has disease labels, nor are they understood in the same way. This means that a diagnostic label may be influenced by region-specific guidelines for the diagnosis of atopic eczema and this may therefore render it difficult to compare estimates of physician-diagnosed atopic eczema prevalence between regions. We thus judged that the lifetime prevalence of atopic eczema symptoms was most likely to prove useful in relation to yielding comparative data on trends in atopic eczema.

 {#s4a}

### Strengths and limitations {#s4a1}

To our knowledge, no systematic review on international disease trends in the incidence and prevalence of atopic eczema has been published. We searched a large amount of potential relevant literature using seven electronic databases and included 69 papers which reported on trends in atopic eczema. These should represent a good coverage of published literature. Furthermore, we searched systematically, according to a protocol and used stipulated inclusion criteria. To ensure that included studies are above a specific quality threshold, the studies were independently quality-filtered by two reviewers. Where a consensus could not be obtained a third reviewer provided arbitration guidance. In contrast with earlier work into this field, we included all reports on atopic eczema trends, whereas previously papers have limited themselves to single estimates of atopic eczema [@pone.0039803-Odhiambo1], [@pone.0039803-Warner1], or to original data from the ISAAC study [@pone.0039803-Asher1], [@pone.0039803-Williams1].

There are gaps in the literature. We could include particularly few reports from the Americas, eastern Europe and Oceania. In general, studies are available on the prevalence of atopic eczema in these regions. However, information from these studies will not be relevant until they are repeated over time. This perhaps somewhat surprising gap for North America is likely to be, at least in part, due to the fact that the ISAAC programme had difficulty identifying a regional coordinator for this region [@pone.0039803-ISAAC2]. We were unable to obtain the full-text translation of one Korean paper. Nevertheless, we are reasonably confident that this report or any other additional reports would be unlikely to undermine our overall findings -- that there is no clear trend in the worldwide incidence and prevalence of atopic eczema. For nearly all regions information on atopic eczema is questionnaire-based. Questionnaires are non-specific and the measured symptoms suggestive of atopic eczema may overlap with symptoms of other conditions, such as contact dermatitis. The ISAAC questionnaire stipulates the typical distribution and the onset of the itchy rash (see [Table 2](#pone-0039803-t002){ref-type="table"}), which helps to enhance its specificity. At the population level and particularly for the purpose of between-population comparison, ISAAC questions are therefore likely to provide adequate symptom-derived prevalence estimates [@pone.0039803-Flohr1]. That said there is inevitably some loss of ability to differentiate between atopic eczema and other differential diagnoses such as allergic contact dermatitis. This problem may have been more pronounced had we also identified studies using the ECRHS; in the event however, no such relevant studies were found to be eligible.

### Future work {#s4a2}

Further research in this area should firstly address methodological issues to help inform the optimum design, execution and reporting of future epidemiological studies of trends in atopic eczema. In our dataset various outcome measures were reported and various assessment tools were used, data were analysed differently across studies and results were reported in different formats (e.g. with and without confidence intervals (CI)), age groups did not match and studies were inconsistently stratified for sex. All of these factors enhance the incomparability of studies. In view of the above, we suggest full and elaborate reporting of the results (including CI) of all of the outcomes obtained. We recommend that the above gaps be addressed using the complete ISAAC tool (and, where possible, also include detailed clinical assessment to allow atopic eczema to be differentiated from allergic contact dermatitis) and be reported according to a standardised format, so that comparisons to other reports on trends are possible. However, even if studies are comparable the prevalence of atopic eczema may still be difficult to compare across countries, without a universal definition. Thus, we need a range of relevant measures of incidence and prevalence as well as a careful description of the diagnostic criteria used together with appropriate interpretation of these data in order to ensure that this important field of epidemiological enquiry progresses in a scientifically robust manner.

### Interpretation {#s4a3}

Although there is no consistent overall global trend in atopic eczema incidence and prevalence, there are some specific trends which are worth remarking upon further, as they may be of interest for research into the aetiology of atopic eczema. Firstly, there was a stable incidence of atopic eczema in 5--6 year olds in West Germany \[12.5% (1991) and 12.8% (1997)\] and a sharply increasing incidence in East Germany \[from 9.6% (1991) to 23.4% (1997)\] [@pone.0039803-Schafer1]. This coincides with the adoption of a "Western" lifestyle in East Germany as a result of political change. A consequence of changed lifestyle and increased socio-economic wealth may be an increased frequency of bathing and a greater availability of soaps and bubble baths, which may remove the skin's natural barrier oils and make atopic eczema more prevalent [@pone.0039803-Cork1]. This is a biologically credible mechanism to explain an increase in incidence -- in particular of mild disease. Nevertheless, Schafer et al. (2000) found that, after adjustment for potential confounders, including socio-economic status, the difference in incidence between East and West Germany remained [@pone.0039803-Schafer1]. Other factors, such as nutritional factors, allergens and irritants or infections may therefore be important in the aetiology of atopic eczema. Political changes resulting in, for example, improved access to physicians in East Germany after reunification or due to changes in disease labelling could also have impacted on measures of the incidence of atopic eczema, as has been noted in relation to asthma diagnosis and prescribing [@pone.0039803-Mommers1]. If this were the case, this would reflect an increase in reporting behaviour rather than any true change in the epidemiology of eczema.

Other trends of interest regarding aetiological hypotheses include diverging trends between neighbouring regions. For example, there are marked increases in lifetime prevalence of atopic eczema symptoms in most countries in Africa \[e.g. in South Africa -- from 15.5% (1995) to 26.2% (2002)\] [@pone.0039803-Zar1], whereas there is a large decrease in Nigeria \[from 26.1% (1995) to 18.0% (2001--02)\] [@pone.0039803-Esamai1]. This anomalous decrease is most likely a consequence of the extremely high baseline prevalence, as prevalence estimates in 2001--02 are largely comparable for all African countries. Rather than a true prevalence, this high baseline estimate may be a reflection of the presence of another skin condition, such as another rash, perhaps caused by parasites, which are common in these regions. In addition, in our dataset there were also marked baseline differences between neighbouring countries. This is indicated by the low baseline prevalence of atopic eczema symptoms in 12--15 year olds in Taiwan \[2.4% (1995--96)\] [@pone.0039803-Lee2] and the much higher baseline prevalence in Korea \[7.2% (1995)\] [@pone.0039803-Oh1]. In these countries too, cultural, social and diagnostic differences may potentially explain this pattern. In contrast, large changes in prevalence estimates within one country in a short space of time are of interest as such changes are likely to represent a true change. For example the doubling in lifetime prevalence of both atopic eczema diagnosis \[from 13.9% (1995--96) to 27.2% (2001--02)\] and atopic eczema symptoms \[from 8.8% (1995--96) to 19.6% (2001--02)\] in boys aged 13--14 in England [@pone.0039803-Shamssain1] is likely to represent a true change and we must consider environmental explanations for this.

In conclusion, we have found no overall trend for the incidence or prevalence of atopic eczema worldwide. However, in Africa, eastern Asia, western Europe and parts of northern Europe (i.e. the UK) trends in atopic eczema prevalence were mainly increasing. There are gaps in the literature, particularly in the Americas and Oceania and for measures of atopic eczema incidence. Future research should investigate trends in what is now one of the most prevalent disorders in Europe and other regions in a scientifically robust manner. In order to do so, the careful use of key definitions, improved study design and more comprehensive reporting are essential.
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